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NITRIC OXIDE SYNTHASE IN CONFINED ENVIRONMENTS:
DETECTION AND QUANTIFICATION OF NITRIC OXIDE
RELEASED FROM CELLS AND MODIFIED LIPOSOMES USING A
SENSITIVE METAL CATALYST-PEDOT MODIFIED CARBON
FIBER ELECTRODE

ABSTRACT
P. A. RESHANI H. PERERA

Nitric oxide (NO) is a freely diffusible, gaseous free radical, associated with many
physiological and pathological processes that include neuronal signaling, immune
response, and inflammatory response. NO is produced from L-arginine in an NADPHdependent reaction catalyzed by a family of nitric oxide synthase (NOS) enzymes. A
deficiency in NO plays a role in hypertension, hyperglycaemia, and arteriosclerosis,
among other pathological states. Conversely, increased NO levels contribute to arthritis,
septic shock, and hypotention. Therefore, measuring and quantifying NO production in
biological systems and matrices may be vital in elucidating physiological and
pathological processes. The goal of this work is to develop an ultra-sensitive and
selective electrochemical sensor taking advantage of NO-sulfur chemistry. In particular,
electropolymerizing 3,4-ethylenedioxythiophene (EDOT) monomers on the surface of
our electrodes yield a suitable sulfur-based polymer PEDOT to be used as an affinity
matrix for NO sensing. In other work, we have shown that the ruthenium (Ru) mediates
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the catalytic oxidation of NO. In this work, we tried to achieve improved sensitivity by
combining both Ru nanoparticles and PEDOT using the layer-by-layer (LBL)
modification method. Further, to eliminate interferences the Ru-PEDOT-Ru modified
carbon fiber was coated with a nafion layer, which acts as an anionic filter. We used our
NO-sensor to accurately monitor NO release from mouse embryonic fibroblast cells as
well as isolated single human umbilical vein endothelial cells.

A second part of this work focused on testing the performance of our sensors in
characterizing NO release from liposomes with confined NOS enzyme. Liposomes are
spherical, closed, self-assembled phospholipids, which enclose part of the surrounding
solvent in their interior. Liposomes can enclose an aqueous medium separate from the
external aqueous medium. Therefore, liposomes can be used as carriers of enzymes (NOS
in this case) without negative impact on the molecular function of the encapsulated
biomolecule and can be considered as a promising way to transport and deliver NO to
targets. We prepared NOS-loaded liposomes and characterized encapsulation efficiency
of various procedures. We also tested the performance of our NO-sensors to monitor and
quantify NO release from NOS-loaded liposomes as potential vehicles for on-site NO
delivery.

vii
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CHAPTER I
NITRIC OXIDE MEASUREMENT IN NOS CONFINED ENVIRONMENT
USING AN IMPROVED SENSOR PLATFORM

1.1 Introduction

It was long thought that NO is just a poisonous, unpleasant, and dangerous gas
and is far from having any physiological implications in living organisms. The discovery
of NO as the vasodilatory messenger spurred a significant increase in research interest in
NO and its roles in biological systems. In fact, NO was named “Molecule of the Year” by
Science magazine [1], and the 1998 Nobel Prize in Physiology and Medicine was
awarded to three scientists: Ferid Murad, Robert F. Furchgott, and Louis Ignarro [2, 3],
for pioneering work discovering the biological roles of NO. Bio-synthesis of this
extremely important molecule involves nitric oxide synthase (NOS), which contains
several cofactors [5]. NO is produce from the terminal nitrogen atom of the substrate Larginine in the presence of NADPH and dioxygen (O2) catalyzed by NOS enzyme.
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Nitric oxide plays a role in a variety of biological processes including
neurotransmission [6-8], vasodilation [9], immune defense, associated dysfunction [10],
inhibition of platelet aggregation [11], and the regulation of cell death (apoptosis) and
cell motility. Due to the wide spectrum of activity of NO, a fluctuation of physiological
NO concentration contributes to a number of pathogeneses of several diseases. A
deficiency of NO production plays a key role in atherosclerosis, hypertension,
hyperglycemia, stroke, myocardial infarction, and ischemia [12-16]. Conversely, an
overproduction of NO is associated with arthritis, septic shock, hypotension, reperfusion
injury and cancer [17]. Thus, for medical and pharmacological approaches, it is important
to identify the change of NO production in biological systems by analyzing NO
concentration.

The analysis of NO release at the single cell level provides a great advantage in
understanding many physiological functions associated with NO. Since NO is a free
radical with a short half-life (<10s), it is react fast with superoxide and other radicals and
with many biological species, such as transition metal ions and molecular oxygen [18,
19]. A sensitive and selective method therefore is required to measure NO in biological
systems. Many indirect and direct approaches for NO detection have been reported [2029], but electrochemical techniques are the most promising methods because they can be
applied for real-time in vivo and in vitro detection of NO with satisfactory temporal and
spatial resolution.
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However, NO can oxidize at various electrode surfaces when sufficiently positive
potentials are applied, in which case a number of other biological intereferents can also
oxidize. Thus, to achieve high sensitivity, as well as high selectivity for NO, the surface
of the electrode needs to be modified in a way that gives high signal priority to NO over
other interfering analytes.

NO can interact with transition metals (such as iron), thiol groups, other free
radicals, oxygen, superoxide anion, unsaturated fatty acids, and other molecules. Some of
these reactions result in the oxidation of nitric oxide to nitrite and nitrate in order to
terminate its effect, while other reactions can lead to altered protein structures, function,
and/or catalytic capacity. For example, NO reacts with S-nitrosylation and converts thiol
groups (including cystein residues) in proteins, to form S-nitrosothiols (RSNOs), which
corroborate the known interaction of NO and sulfur-containing groups [30]. Our first aim
here is to develop an ultra-sensitive electrochemical sensor that takes advantage of NOsulfur chemistry for accurate quantification of NO in biological systems. Considering the
catalytic electro-oxidation of NO on the surface of transition metals [31-34],
incorporation of metal catalyst with sulfur compounds would be an ideal approach to
achieve required sensitivity for NO detection.

Accurate and reliable quantification of NO in biological systems provides a great
advantage to identifing and understanding the pathogenises diseases that can open up
correct avenues to treat disease states. The transpotation of the NO/NOS enzyme, which
can supply NO flux, is one of the approaches to treat disease states that are associated
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with the deficiency of NO. Liposomes have been considered as effective carriers of
protein because of their ability to trap an aqueous solution separated from the external
aqueous medium. Thus, our goal in the second part of this work is to development of
NOS loaded liposomes as a platform for NO delivery to targets.

1.2 Properties of NO

Nitric oxide is a colorless gas that contains 46.68 % nitrogen and 53.32 % oxygen
at typical conditions. The molecular weight of NO is 30.01 g/mol, while the boiling point
and melting point are -151.7 oC and -163.6 oC respectively. The nitrogen and oxygen
atoms are bound by a double bond with the bond order of 2.5, leaving two pairs of nonbonding electrons on the oxygen atom and one pair of non-bonding electrons and one
unpaired electron on the nitrogen atom as shown in the following Lewis structure.

N

O

Due to the free radical on the nitrogen atom, NO is very reactive and thus
extremely unstable. NO cannot maintain its original form for very long in a biological
environment. The hydrophobic nature of NO makes it diffusible through the biological
membrane. As a result, NO undergoes complex changes immediately after being
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released. The possible reactions of NO in physiological conditions are shown in Figure
1.1.

RNH2
RSH + O2
RSOH
sufenic acid

-5e

NO2-

.

NO.

O2
superoxide-

Reactive nitrogen intermediate
Guanidino nitrogen of L-Arg

RSH

H+ + e

-1e
RSNO
nitrosothiol

-

peroxynitrite OONO

NO2- nitrite
ntrite

+

H

-1e
OONOH
peroxynitrirous acid
NO2 nitrogen dioxide
-1e

.

NO2 ...OH

.
NO3-

nitrate

Figure 1.1. Reaction of NO-related compounds in a biological environment. Adapted
from reference [35].
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NO readily reacts with molecules with unpaired electrons that are classified as
free radicals (O2. -superoxide, OH. -hydroxyl ion) or transition metals like heme iron
(myoglobin, hemoglobin, cytochromes). Therefore, the above radicals reduce the
bioavailability of NO. The final products of NO reactions vary depending on the system
within which the reactions occur. The main oxidative product of NO in in vitro systems,
is NO2- (nitrite), but, in vivo, NO undergo sequence of reactions with hemoglobin and
other biological compounds and end up with NO3- (nitrate) as the main degradation
product [35]. In biological systems NO reacts with oxy-myoglobin to form nitrate and
methemoglobin (MetHb) or metmyoglobin (equation 1.1) [36]. This reaction is identified
as the NO regulatory mechanism for control NO concentration in vivo. Therefore, the
specificity of NO towards transition metals allows the target tissue to receive the
information based on the NO concentration.

Hb(Fe-O2) + NO

MetHb( Fe(III)) + NO3-
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Equation 1.1

1.3 Nitric oxide production in biological systems

Nitric oxide (NO) is produced from the guanidino group of L-arginine in an
NADPH-dependent reaction catalyzed by a family of NO synthase (NOS) enzymes [37].
Arginine and oxygen are converted to NO and citrulline by the enzyme NOS. The
chemical reaction in Figure 1.2 illustrates the NO production by NOS enzymes and the
scheme 1.1 shows the participation of cofactors of NOS in NO production.

COO-

+H3N

COO-

+H3N

Tetrahydrobiopterin
FMN, FAD, NOS
NADPH
O2

NH

H2N

L- Citrulline

N- Hydroxy- Arginine (NHA)

L-arginine

NH2+

COO-

+H3N

Tetrahydrobiopterin
FMN, FAD, NOS
NADPH

H2O

NH

H2N

O2

N

Nitric Oxide

+

H2O

NH

H2N

OH

Figure 1.2. The reaction of NO production by means of NOS enzyme.
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O

NO

NADPH
Oxygenase
eFAD

NADP
H+

eFMN

e-

+

BH4
Fe

L-arginine
+
O2

Reductase

L- Citrulline
NO

Scheme. 1.1 The overall reaction is catalyzed and the cofactors of NOS electrons (e-) are
donated by NADPH to the reductase domain of the enzyme and proceed via FAD and
FMN redox carriers to the oxygenase domain where they are used in the activation of
oxygen in the presence of L-arginine. Citrulline and NO are generated as products.
Adapted from [38].
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1.4 Nitric oxide synthase

The NOS enzymes belong to the heme-containing family of enzymes called
monooxygenases [39]. Depending on the expression, activity, and the structure, there are
three distinct isoforms of NOS that exhibit multiple physiological and pathological
functions. The three NOS groups are neuronal NOS (nNOS), inducible NOS (iNOS), and
endothelial NOS (eNOS) [40].

The iNOS is expressed in many cell types mostly in response to inflammatory
cytokines. In a majority of cell types, iNOS level is either very low or undetectable. Since
production of NO by iNOS can be controlled through transcription, stimulation of the
cells can lead to increased transcription of the iNOS gene, with the subsequent production
of NO. The nNOS is expressed in neuronal cells and skeletal muscles. On the other hand
the eNOS protein is identified in endothelial cells. NO produced by eNOS has an
important role in the regulation of vasodilation and antithrombotic actions [40].

Increases in intracellular calcium levels lead to an ephemeral increase in NO
production by binding eNOS and nNOS to the increased level of calmodulin. In contrast,
iNOS activity is not able to respond to changes in calcium levels in cells because iNOS
can bind so strongly to calmodulin even at very low levels of cellular calcium [41]. The
nNOS and eNOS isoforms are constitutively expressed and regulated by calcium levels,
which are associated with calmodulin interactions. The calcium-calmodulin complex
stabilizes the NOS dimer and BH 4 is essential for NOS dimer formation.

9

NOS exhibit a bidomain structure in which an N-terminal oxygenase domain
containing binding sites for heme, tetrahydrobiopterin (BH4) and L-arginine is linked by
a CaM-recognition site to a C-terminal reductase domain that contains binding sites for
FAD, FMN and NADPH [42-45]. Both domains are catalytically active. Reconstitution
of the second step of NO synthesis has been achieved by combining the reductase and
oxygenase domains of human eNOS and murine iNOS [46]. The general structure that
shows both domains of NOS enzymes is illustrated in Figure 1.3.

10

Figure 1.3. Schematic diagram of Nitric Oxide Synthase adapted from [42].

1.5 Biological function of NO

As explained earlier, NO is an extreamely important and versatile messenger in the
biological system. At first, it was recognized as an endothelium-derived relaxing factor in
the vascular system [47]. It has also been identified as a neurotransmitter or
neuromodulator in the neuronal system [41] and a cytotoxic factor in the immune system
[33, 47-54]. In addition, it is believed that NO is related to some tissue damage, such as
ischemia/reperfusion tissue damage [55, 56] and excitatory neuronal death [57-59].
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1.5.1 NO in the vascular system

The endothelium (inner lining) of blood vessels use NO to signal the surrounding
smooth muscles to relax, thus dilating the arteries and increasing blood flow. NO
produced by eNOS

diffuses into the vascular smooth muscle cells adjacent to the

endothelium and activates guanylyl cyclase by binding to it. The guanylyl cyclase
enzyme catalyzes the dephosphorylation of guanylyl triphosphate (GTP) to cyclic
guanylyl monophosphate (cGMP), which serves as a secondary messenger for carring out
important cellular functions, especially for signaling smooth muscle relaxation.

The production and hence the concentration of NO is elevated for humans at highaltitudes, which helps people avoid hypoxia. In such situations, nitroglycerin and amyl
nitrite act as vasodilators because they are converted to nitric oxide in the body. Nitric
oxide contributes to vessel homeostasis by inhibiting vascular smooth muscle contraction
and growth, platelet aggregation, and leukocyte adhesion to the endothelium.
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1.5.2 Neuronal NO

NO is also generated in neuron cells in the central or peripheral nervous systems
[60]. The nNOS is activated with an intracellular calcium increase through agonistreceptor interactions. In the peripheral nerve system, the main function of NO is
vasoregulation [36]. In addition to its direct action, renal blood flow is regulated
indirectly with NO through the reduction of sympathetic neuronal activity [61, 62]. Nerve
cells tend to die from over-stimulation of excitatory neurotransmitters or agonists. NO or
the NO donor leads to marked neurotoxicity [63], by the production of toxic compounds,
such as peroxynitrite (ONOO-), which form in the reaction of NO and superoxide (the
reduced form of oxygen).

1.5.3 NO in the immune system

Immune cells (Macrophage, nuclephile, monocyte, and kuppfer cells) release a
greater amount of NO than endothelium or nerve cells by activating inducible NOS
(iNOS). The iNOS can be induced with the stimulation of cytokines or
lipopolysaccharide (LPS) [64]. The NO produced from iNOS has cytostatic and cytotoxic
effects on invading microorganisms or tumor cells [65]. The effect of the cytotoxicity is
found in two categories. First is the inhibition of the respiration of mitochondria [66].
The enzymes that have an Iron-sulfur center in their catalytic site can strongly interact
with NO and ultimately inhibit and terminate the electron transfer system. Second is the
direct modulation to the DNA synthesis, which can inhibit some enzymes [67].
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Lipopolysaccharide (LPS), which is a constituent of the bacterial outer membrane, may
cause a decrease in blood pressure, cardiovascular and kidney damage, and bleeding in
some organs. In such environments, NO production and concentration increase, and,
hence, a drop in blood pressure occurs immediately [68].

1.6 NO detection in live cells

The cell is the smallest structural unit of biological life. These microscopic
systems have many functions such as energy metabolism, intra and intercellular signaling
by chemical and electrical means, and self-reproduction. Due to the ultra-small size of
single cells (diameter 7–200µm, volume fL–nL), ultra-trace amount of component
(zmol–fmol), and ultra-rapid biochemical reaction (ms), highly efficient, highly sensitive,
and highly selective detection methods are necessary for single cell analysis.

Combining capillary electrophoresis (CE) with the detection of laser-induced
fluorescence (LIF), electrochemical detection (ED), and mass spectrometry (MS) enable
direct intrinsic studies of single cells [69]. These systems are based on conventional
technologies and instrumentation. They give only limited information about the cell
content and do not present a general method for single cell analysis. Electrochemical
methods such as amperometry and voltammetry are suitable methods to measure subnanomolar levels of oxidizable chemicals such as NO, which are secreted from a single
cell.
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As described in section 1.1, NO is involved in many important physiological
processes. Therefore NO level in biological systems is under intense investigation as a
therapeutic target for variety of conditions. A deficiency in NO plays a role in
hypertension, hyperglycaemia, arteriosclerosis, Parkinson's disease, and Alzheimer's
disease [51-53]. Conversely, increased NO levels contribute to arthritis, reperfusion
injury, and cancer [48-50]. Thus, it is important to measure and quantify the amount of
NO production in biological matrices to elucidate the physiological and pathological
processes related to NO production and release.

1.7 Detection of NO

The field of NO detection techniques has grown rapidly due to the need of
understanding the physiological and pathological functions of NO. With the high
reactivity and short half-life of NO, direct detection of NO in biological systems is a
demanding task.

There are number of methods available for NO measurement, including mass
spectrometry, spectrophotometry, chemiluminescence and electron paramagnetic
resonance [70, 71]. Most of these approaches rely on the measurement of secondary
reaction products (e.g., nitrites and nitrates, Hemoglobin-Fe3+ and

L

-citrulline) and

formation of stable adducts (e.g., hemoglobin–Fe2+ –NO and other NO–iron complexes)
that require sample processing. They do not allow real time measurements of endogenous
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NO production; they also provide complementary information that is difficult to translate
into the NO concentration dynamics in tissues.

Spectrophotometry measurements of NO are based on the measurement of
absorbance of colored compounds, which are complex with NO or its secondary reaction
products. There are two main spectrophotometry methods: Griess assay [22] and
hemoglobin-dioxy assay. In Griess assay, nitrite and nitrate, the biological metabolites of
NO, produce the diazonium ion with sulfanilic acid, which couple with N-(naphthyl)
ethylenediamine to form a colored complex of chromophoric azo-derivative [72]. On the
other hand, in hemoglobin dioxy assay, the shift of the Soret band (due to reaction of
hemoglobin-dioxy with NO to form methemoglobin) accounts for the quantification of
NO. These methods are inapplicable in biological samples due to the lack of sensitivity
and a deprived detection limit.

The chemiluminescence technique [25, 73] is a direct method to measure NO and
is based on the reaction of NO with ozone (O3). The reaction forms the excited state NO2
and can emit photon when it reverts to the lower energy states, which is proportional to
the NO concentration. However, bulk instrumentation and time and reagents are not
compatible with real time measurement of NO. A number of methods of NO-trapping
techniques have been developed for the detection of NO. The spin-trapping approach is
widely used, where the additional reactions of NO with other compounds form EPRactive and stable adducts [74, 75]. This strategy has also drawbacks, such as high cost,
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large equipment size, and need of specialized operators and special ion trap, and
therefore, does not allow real time analysis of NO.

From this angle, electrochemical methods are very attractive alternatives for
monitoring NO concentration in situ. The use of microelectrodes for the electrochemical
detection of NO in tissues makes real time measurements possible due to the high
temporal resolution. The small size of these microelectrodes (0.5–35 μm diameter) allows
a high spatial resolution and makes them excellent sensors for direct placement into
biological preparations, without causing extensive damage to tissues [54, 76-78].

Electrochemical detection of NO involves the oxidation of NO on the surface of
the working electrode, which produces a Faradaic redox current. (Equation 1.2).

NO

Equation 1.2

NO+ + e-
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1.8 Electrochemical NO Sensors

The first electrochemical electrode for detecting NO in biological samples was
published by Shibuki [77], where a platinum wire was used as the working electrode and
a silver wire was used as the counter/ reference electrode in the Clark-type probe. The
current is generated by oxidation of NO measured at a constant potential of +0.9 V vs. Ag
wire.

One of the commercially available NO sensor was developed by World Precision
Instruments, (WPI) [29] . This sensor called the “ISO-NOP” and the modified platinum
wire disk covered with the NO-selective membrane was used as the working electrode,
and the Ag/AgCl electrode was used as the reference electrode. Although the sensor has
advantages in measurement of NO, due to the fragility of the membrane and the difficulty
in calibration, the real time analysis is complicated.

Due to the high reactivity of NO and the low concentration of NO in biological
systems, the direct electro-oxidation of NO on the electrode surface does not produce a
significantly high response. Therefore, to achieve high sensitivity, the surface of the
electrode needs to be modified with a supportive compound to amplify the NO signal.
There are two major types of surface-modified electrodes that are suitable for the
oxidative determination of NO. The first type works by direct oxidation of NO at
sufficiently high electrode potential using gas permeable membranes to enhance
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selectivity. The second type is based on the coating of the electrode surface with suitable
modifiers.

Different types of sensors have been developed to detect NO by modifying the
surface of the electrode, for example: metal compounds [79, 80], organometallic
compounds (such as Fe, Ni, Mn, Cu) [28, 29, 79, 81, 82], enzymes [83], and polymers
[31, 84-87]. The performances of these sensors vary depending on the materials and the
method used to modify the surface, the potential used to NO oxidation, and other
experimental conditions. Despite the advantages of such sensor designs their application
in biological systems is limited due to low sensitivity, low selectivity, and slow response
time, the application of these sensors in the biological systems is limited.

The layers of the deposited polymer films have better analytical properties, such
as selectivity, sensitivity or stability. In fact, most of the described microelectrodes are
based on a conventional two or three-polymer films design with each film performing
specific tasks [32, 33]. In a general case, applications of chemically modified electrodes
to solve analytical problems require reproducible preparation procedure of the modified
surfaces and an accurate control of the permeability characteristics of the electrode
coatings. Electro-polymerization of suitable monomers is ome method of electrode
modification use to achieve controlled layer [32, 33, 54]. The additional advantage of the
electro-polymerization design is the ability to coat very small or narrow-sized electrode
surfaces.
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1.9 NO and Sulfur Interactions

In living bodies, nitric oxide tends to react rapidly with oxygen and superoxide, as
explained in section 1.2, and forms other oxides of nitrogen, some of which are toxic.
However, the lifetime of NO is extended, and the concentration of the free NO is
regulated through its binding with several acceptors, such as metals (binding of NO with
the heam in hemoglobin) and thiols.

Iron nitrosyls and nitrosothiols are the most important agents that account for the
storage and transport of the NO and related compounds. Most of the target receptors of
NO also contain an iron center and thiol groups. Nitrosothiols and metal nitrosyl
complexes belong to important external sources of nitric oxide (NO-donors), and
complex interactions are observed in ternary iron–sulfur–nitrosyl systems [30].

Biological functions of nitric oxide and its redox forms are essentially related to
the chemistry of thiol groups [88] and transition metal centers [89] present in various
biomolecules. Regulatory properties of nitric oxide are based on interactions with iron
and sulfur moieties. Redox properties of iron centers are considerably modulated with
protein-bound thiols and nitric oxide. They can interact mutually with each other, and
these interactions may account for important physiological and pathophysiological
processes.
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S-Nitrosothiols (thionitrites) have very important physiological roles and
considered as the principal stores of NO. [30]. They participate in NO redox changes as
illustrated in scheme 1.2, which are the source of thiyl radicals; they are also involved in
other regulatory processes.

RS-

RS-

RS.

RS. (RSSR)

H3O+

NO2

-

H3O.

NO+

OH-

M(n-1)+

+e-e-

.

NO

Mn+

+e-e-

N2O

NORSH

NH2OH

M(n-1)+

Scheme 1.2. Interconversion of different redox forms of nitric oxide in reaction
with biologically relevant reducers and oxidants (M = Fe, Cu, Co). Adapted from
[90].
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Nitrosothiols are usually formed in reactions between thiols and various
nitrosation agents, including nitric oxide in the presence of electron acceptors,
nitrosonium salts, nitrous acid and inorganic nitrites, metal nitrosyl complexes and many
others [91]. S-Nitrosothiols are typically unstable and undergo spontaneous
decomposition via homolytic cleavage of the S-N bond according to the Equations (1.3)
and (1.4) [30]:

RSNO → RS• + NO•

Equation 1.3

2RS• → RSSR

Equation 1.4

The strength of the S-N bond is controlled by the RSNO thermal stability.
Typically, the S-nitrosothiols bonds become more stable as the contribution of the
resonance structure (II) becomes higher (Figure 1.4), which is affected by the electron
releasing substituents.
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Figure 1.4. Resonance structures of S-nitrosothiols.

Because of the generally favorable S-NO interactions, the development of a sulfur
based NO sensor is an ideal approach to achieve required sensitivity towards NO
oxidation. As a sulfur-containing compound we used a conductive polymer, poly 3,4ethylenedioxythiophene (PEDOT), to modify the electrode surface. The combination of
deposited polymer film brings better analytical properties, such as selectivity, sensitivity
or stability. Prior work in overlab show advantageous catalytic properties of transition
metal ruthenium, therefore we used the ruthenium with combination of PEDOT to
achieve the synergetic performances. In this work we report the development and the
performances of sulfur based NO sensor in measuring NO released from live single cells
and cell collection as well as from modified liposomes.
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1.10 NOS encapsulation in liposomes

Liposomes are spherical, closed, self-assembled phospholipids, which enclose
part of the surrounding solvent in their interior. Liposome and micelles, considered as
precursors of a protocell [92, 93], served to provide the compartment that functions like a
minimal cell where biological activities take place [94-96]. The lipid bilayers that
liposomes made up have been considered as models of biomembranes. Because
liposomes are closed vesicles with no exposed hydrophobic edges, they are energetically
more favorable structures than open membranes. The most important quality of
liposomes is their ability to enclose an aqueous medium separate from the external
medium. Thus, it is considered as a simple-model system to study cellular properties.

Depending on the number of bilayers, liposomes can be named as multilamellar
vesicles (MLV) and unilamellar (ULV) vesicles (Figure1.5). Multilamellar vesicles do
not represent a well-defined system and are not often used in scientific experiments.
Vesicles with a size of 1-300 µm are considered giant vesicles (GV), and vesicles in the
nanometer size are considered small vesicles (SV)[4].
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Figure 1.5. Schematic diagram of different kinds of

liposomes. (A) Multi

lamellar vesicles (B) Large unilamellar vesicles (C) Small unilamellar liposome
(D) Multivesicular vesicles. (Reprinted from reference [4])
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Due to their unique properties, liposomes are used for drug delivery. Hydrophobic
chemicals can be dissolved into the membrane and the hydrophilic compounds can entrap
in their hollow microenvironment. Therefore, liposomes can carry both hydrophobic
molecules as well as hydrophilic molecules. To deliver the molecules to sites of action,
the lipid bilayer fuses with other bilayers, such as cell membranes. Figure 1.6 shows the
schematic diagram of one of the liposomal drug delivery mechanisms to the target cells.
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Figure 1.6. Representation diagram to show the drug delivery mechanism (fusion) to
target cells by liposome.
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The investigation of the use of liposomes as protein carriers has gained great
interest for a number of potential applications in pharmaceutical formulations.
Concerning the liposomes in genomic and medical applications, a large measure of
proteins, notably enzymes, has been used. The attractiveness of liposomes as a
enzyme/protein delivery system is due in part to the fact that the encapsulated proteins
remain in their preferred aqueous environment within the vesicles, while the liposomal
membrane protects them against destabilizing exterior agents such as proteases [97, 98]
and protects the enzyme from self-denaturation and dilution effects. In addition to its
stabilizing effect, the usefulness of liposomes is extended as enzyme carrier systems in
biotechnological applications. The undemanding ability of entraping of substances inside
liposomes and the possibility to regulate entrance of substance or exit of product from the
membrane of liposome gained considarable interest of drug delivery innovation. Protein
encapsulation in liposomes would be a great success in vaccine development, in protein
absorption enhancement, and in drug delivery. In this study we investigate the
encapsulation of nitric oxide synthase (NOS) enzyme inside liposomes for possible
delivery to deficient target sites.
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CHAPTER II

DEVELOPMENT OF HIGH SENSITIVE AND SELECTIVE NO SENSOR USING
A CARBON FIBER MICROELECTRODE MODIFIED WITH AN
ELECTROCONDUCTIVE POLYMER (EDOT) AND THE TRANSITION
METAL CATALYST RUTHENIUM (Ru)

2.1 Introduction

Nitric oxide (NO) is a freely diffusible, gaseous free radical associated with many
physiological and pathological processes. Biologically relative processes include
neuronal signaling, immune response, inflammatory response, modulation of ion
channels, platelet adhesion and activation, and cardiovascular homeostasis as well as
antitumor activities [1, 2]. Nitric oxide is produced from one of the terminal guanidino
nitrogens of L-arginine in an NADPH-dependent reaction, which is catalyzed by nitric
oxide synthase (NOS) enzyme. Understanding its biological role requires the
measurement of NO in situ and in real time in a selective, sensitive, and quantitative
manner. Due to the short lifetime and the lower levels of NO released by biological
systems, its direct determination has been a challenging task [3]. Different approaches for
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NO quantification were reported, including spectrophotometry, mass spectrometry,
chemiluminescence, and electron paramagnetic resonance [4, 5]. These methods rely on
the measurement of the products (e.g., nitrites and nitrates, hemoglobin-Fe3+, and Lcitrulline) of NO reactions with oxygen, hemoglobin, and other biological complexes
(e.g., Hemoglobin–Fe2+–NO). Real time measurement of endogenously produced NO is
difficult for these techniques, because they require sample processing prior to the analysis
and provide indirect information that has to be converted to NO concentration.

Electrochemical approaches are promising techniques for direct monitoring of NO
concentration in situ; in fact, studies on various types of electrode materials that are
sensitive for NO have been published [6, 7]. Electrochemical techniques using carbon
fiber electrodes (CFEs) have demonstrated several advantages such as simplicity, fast
response and ease of handling. Electrochemical detection of NO using CFE involves the
oxidation of NO on the surface of the electrode, which produces a Faradaic redox current.

The design of the microelectrodes for electrochemical detection of NO allows real
time measurements in vivo due to the high temporal and spatial resolution. The
appropriate dimensions allow the direct implantation of the microelectrodes into microsliced tissues and even single cells without consequential damage. Nitric oxide molecule
can be oxidized at various electrode surfaces if sufficient positive potentials are applied,
in which case a number of other biological interferents can also oxidize. To achieve high
sensitivity and high selectivity for NO, the surface of the electrode needs to be modified
in a way that gives priority and a high signal to NO over other interfering analytes. Thus,
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it is essential to use different materials to modify the surface, each of which performs
different tasks and provides improvement to analytical properties, such as selectivity,
sensitivity, or stability. Electrochemical modification of electrode surfaces with
electroactive polymers led to important development in analytical measurements with a
reproducible surface preparation procedures and close control of electrode coatings [810].

Success of NO measurement can be achieved by selecting a polymer film on the
electrode surface with a high affinity for NO. Several kinds of polymer-modified
electrodes

have

been

reported,

which

involve

metal

phthalocyanines

[11],

metalloporphyrins [12, 13], and pyrrole and its derivatives [14, 15]. Although such sensor
designs offer some advantages for NO detection. Their use in direct measurement of NO
in biological system was limited, due to low sensitivity, high detection limit and slow
response time.

NO can interact with transition metals such as iron, thiol groups, other free
radicals, oxygen, superoxide anion, unsaturated fatty acids, and other molecules. Some of
these reactions result in the oxidation of nitric oxide to nitrite and nitrate, while other
reactions can lead to altered protein structure, function, and/or catalytic capacity. For
example, NO reacts with S-nitrosylation and converts thiol groups, including cysteine
residues in proteins, to form S-nitrosothiols (RSNOs) [16-19]. Nitrosothiols and iron
nitrosyls are the most important agents that account for the storage and transport of NO
and related compounds. Most target receptors of nitric oxide also contain the iron center
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and thiol groups [16]. Therefore, it is obvious that sulfur and NO have unique affinity to
each other. Thus, to improve electrochemical detection of NO electrode modification
with sulfur compounds may provide a beneficial approach. This approach may lower the
oxidation potential of NO due to sulfur-NO interactions.

One goal of this work was to develop an ultra-sensitive and selective NO
electrochemical sensor taking advantage of NO-sulfur chemistry for accurate
quantification of NO in biological systems. In particular, PEDOT was used by
electropolymerizing EDOT (3,4-ethylenedioxythiophene) monomers to modify the
electrode to increase the sensitivity of the sensor towards NO. The amount of redox
current typically generated by the oxidation of NO released by biological systems is
extremely small. Thus, the design of an electrode for NO detection requires enormously
sensitive electronic and ultra-low noise amplification circuitry. Our previous studies
showed that the transition metal Ru mediates the catalytic oxidation of NO. This
enhancement is the result of the electrocatalytic response of Ru oxide nanoparticles in the
presence of NO. Therefore, we tried to achieve the improved sensitivity of a PEDOT
modified electrode by combining both Ruthenium nanoparticles and PEDOT using the
layer-by-layer (LBL) modification method. The CFE was modified first with ruthenium
nanoparticles as described in literature; [20] then, EDOT was polymerized on top of the
Ru particles and again a Ru-layer is deposited on top of the PEDOT layer. Further, to
eliminate the other interferences the Ru/PEDOT modified carbon fiber was coated with a
Nafion layer, which acts as an anionic filter [21, 22].
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Surface morphology of modified fibers was characterized using Field Emission
Scanning Electron Microscope (FESEM). Atomic Force Microscopy (AFM) was used to
analyze the surface morphology as well as film thickness of the PEDOT thin layer
deposited on the surface of Ru film. Energy dispersive X-ray spectroscopy (EDS) was
used to further study the more detailed surface composition of the Ru and PEDOT film
coated on the electrode.

2.2 Experimental Section

2.2.1 Chemicals and reagents

3,4-ethylenedioxythiophene, acetonitrile (99.93% HPLC grade), NaH2PO4,
NaHPO4, pyrogallol, KOH, hemoglobin, RuCl3.xH2O and sodium hydrosulfite were
purchased from Sigma-Aldrich (St Louis, MO). Carbon fibers (7-µm and 30-µm) were
obtained from Goodfellow (Devon, PA) and World Precision Instrumentation (Sarasota,
FL), respectively. Highly Oriented Pyrolytic Graphite (HOPG) surfaces (SPI-1 Grade)
were purchased from SPI suppliers (West Chester, PA). Silver conductive epoxy was
purchased from Chemtronics (Santa Ana, CA). All stock solutions were prepared with
nanopure-deionized water from a Barnstead water purification system model D8961
(specific resistance >18.2 Ω cm). All other chemicals were analytical grade and were
used as received.
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2.2.2 Electrochemical apparatus and electrode materials

Amperometric measurements were performed using a CHI-440 electrochemical
workstation. All potentials reported here are versus a Ag/AgCl reference electrode. A
platinum wire was used as the auxiliary electrode and modified or unmodified carbon
fibers (7- and 30-µm) were used as working electrodes. UV-visible absorbance spectra
were recorded on Agilent 8453 spectrophotometer using 1-cm path UV-visible cells.

The morphology of the unmodified and modified CFEs was imaged using the
field emission scanning electron microscope (FESEM) Hitachi S-4500 equipped with
energy dispersive X-ray (EDX) elemental analysis capability. Atomic force microscope
(AFM) (Molecular Imaging Corp, Tampe, AZ) was used in high resolution surface
characterization.

A homemade flow-cell was fabricated with transparent plexiglass to insert a
carbon fiber microelectrode, an Ag/AgCl reference electrode, and a stainless steel
auxiliary electrode tube that was also used as the outlet. A Masterflex peristaltic pump
and a Rheodyne 5020 manual injector (Sigma-Aldrich Corp, St. Louis, MO) with a 500μL-injection loop were used to inject NO solution into the buffer stream in flow-cell.
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2.2.3 Electrode Preparation

The 7-µm and 30-µm diameter carbon fiber microelectrodes were prepared using
published methods described elsewhere [23]. Briefly, fibers were isolated and sonicated
in acetone, then in nitric acid (1:1), and finally in distilled water. A single dried fiber was
mounted on the end of a copper wire using conductive epoxy compound. After the tip of
the manually pulled glass capillary was cut to obtain a smooth blunt opening (25-35 µm
diameter), each carbon fiber was inserted into the glass capillary and sealed with nonconductive epoxy. The copper wire was fixed to the stem of the glass tube with epoxy
glue and dried prior to use. After the epoxy had cured, the tip portion of carbon fiber was
cut, leaving 3 mm of the fiber protruding.

All electro-deposition and electro-polymerization experiments were performed in
a three-electrode cell on a BAS electrochemical workstation that stood at room
temperature. EDOT polymerization was done by using 0.05 M EDOT in the presence of
0.1 M tetrabutylammonium tetrafluoroborate in acetonitrile solution at a potential range
from +1.5 V to -1.5 V and at a scan rate of 250 mV/s. For Ruthenium nanoparticle
modification, 0.02 M RuCl3 in 10 mM perchloric acid solution was used and
electrodeposited in the potential range of -0.85 and +0.65 V at 100 V/s over 20 minutes.
A silver chloride (Ag/AgCl) electrode was used as the reference electrode, unless
otherwise indicated. Platinum wire and unmodified or modified carbon fiber electrodes
were used as auxiliary and working electrodes. After each modification, the electrode was
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gently washed with nanopure-deionised water to remove excess material and allowed to
dry prior to use.

2.2.4 Preparation of NO stock solution

NO stock solution was prepared by bubbling purified NO gas through nanopuredeionized water [24]. A small glass vial containing 10 ml deionized water and capped
with a rubber septum was treated with purified nitrogen passing through an alkaline
pyrogallol (5% w/v) solution for 30 minutes. Then purified NO gas was bubbled through
the treated water for another 30 minutes in a fume hood. The purified NO gas was
prepared by passing the gas through a 5% pyrogallol solution in saturated potassium
hydroxide to remove oxygen and then through 10% (w/v) potassium hydroxide to remove
other nitrogen oxides. The concentration of the NO saturated water was 2 mM, which
was confirmed by a photometric method based on the conversion of NO by
oxyhemoglobin to methemoglobin [25]. The NO standard solution was freshly prepared
by serial dilution of the NO saturated solution prior to each experiment.
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2.2.5 Experimental procedure

The amperometric measurements were performed using CHI electrochemical
station. The pH 7.0 phosphate buffer was purged with purified nitrogen gas for at least 20
minutes prior to the experiments to remove dioxygen; a nitrogen blanket was kept on the
electrochemical cell throughout the experiment. Amperometric experiments were
performed by applying +0.5 V potential at the working NO-sensing electrode. A
moderate stirring of the solution was maintained at about 250 rpm, which allowed the
transient background current to decay to a steady-state value in the absence of NO. An
airtight Hamilton syringe was used to inject the different concentrations of NO into the
buffer solution.

2.3 Results and Discussion

2.3.1 Electrodeposition of EDOT on CFE

The polymerization of EDOT on the electrode surface was performed
electrochemically using multiple scan cyclic voltammetry on the carbon fiber electrode.
A regular growth was observed for PEDOT in the potential window from +1.5 V to -1.5
V and at a scan rate of 250 mV/s. An increase in both anodic and cathodic current was
observed during the electropolymerization process. Typical cyclic voltammograms
recorded during the film formation are shown in Figure 2.1. The mechanism of the
polymerization of water insoluble monomers on conductive surfaces has been addressed
in the literature [26]. This process ultimately led to the formation of the polymer PEDOT
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on the surface of the electrode as illustrated in scheme 2.1. Scan rate dependence
experiments for the current response during redox cycling of EDOT between +1.5 V and
-1.5 V were also conducted and results were in line with the deposition of a conductive
polymer on the surface. For the polymerization process, we adopted the use of 10
continuous cyclic scans and the scan rate of 250 mV/s as optimum conditions. Large
number of scans (above 12) and or higher scan rates led to very unstable film and
affected the reproducibility of NO measurements.
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Figure 2.1. Cyclic voltammograms showing electro-deposition of EDOT by continuous
cyclic scaning between +1.5 V and –1.5 V in a solution containing 0.05 M EDOT in the
presence of 0.1 M tetrabulyl ammonium tetrafluoroborate in acetonitrile solution. Scan
rate: 250 mV/s.
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Scheme 2.1. Polymerization of EDOT on the electrode surface.

In order to enhance the sensitivity of a PEDOT modified electrode, Ru
nanoparticles were electrodeposited on the electrode in alternate layers with PEDOT
layers.

In this case, ruthenium nanoparticles were deposited on the CFE

electrochemically from a RuCl3 solution. Then, the PEDOT layer was polymerized on the
top of the Ru particles; subsequently, Ru particles were again deposited on top of the
PEDOT layer to get three successive layers (Ru-PEDOT-Ru).
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2.3.2 Characterization of modified microelectrodes

The FESEM micrographs of PEDOT polymerized fiber samples (Figure 2 B, D)
showed thicker morphology, resembling a “cauliflower” type of coating, compared to
uncoated carbon fibers (Figure 2.2 A, C). This coating apparently increases the surface
area of the electrode. Due to the grooves present on the surface of 7-µm fiber (Figure 2.2
C, D), it was found that the deposition of PEDOT on the 7-µm fiber was higher than that
of 30-µm fiber (Figure 2.2 A, B). The surface morphology of electrodeposited ruthenium
oxide on the carbon fiber surface appears as the characteristic granular-type structures
(Figure 2.3 A, B). In the sequential deposition modification, the surface morphology of
the Ru film was changed from a small granular type to cauliflower type with many
recesses after the polymerization of PEDOT on the Ru surface as shown in Figure 2.3 C,
D [27]. FESEM images of the Ru-PEDOT-Ru modified fiber showed small Ru granules
on the top of PEDOT layer (Figure 2.3 E, F), as expected for the sequential
electrodeposition.
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A
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Figure 2.2. FESEM images of CFEs- unmodified 30-µm (A); PEDOT modified 30-µm
(B); unmodified 7-µm (C); PEDOT modified 7-µm(D);
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Figure 2.3. FESEM images of CFEs- Ru Modified CFE 1000x (A); Ru Modified CFE
30000x (B); Ru-PEDOT 1000x (C); Ru-PEDOT 20000x. (D); Ru-PEDOT-Ru modified
CFE 1000x and (E); Ru-PEDOT-Ru modified CFE 30000x (F).
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The same modification procedures for Ru deposition and PEDOT polymerization
were applied to modify the highly oriented pyrolytic graphite (HOPG) surface for AFM
analysis. AFM images shows that the thickness of the modified surface or the PEDOT
film is ~200 nm (z height) (Figure 2.4 B). The AFM image of the PEDOT-Ru layer-bylayer modified surface shows the full coverage of Ru nanoparticles on the top of the
PEDOT film. The z height of Ru nanostructures alone was found to be around 2 nm,
which is very small compared to that of the PEDOT layer. Therefore, sequential
deposition of Ru on the PEDOT surface did not adversely affect the thickness of the
PEDOT film (Figure 2.4 C).
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B

A

C

Figure 2.4. Contact AFM topological images for (A) unmodified HOPG surface (B) PEDOT
modified HOPG surface (C) Ru on the top of the PEDOT surface. Scale bar is 500 nm.
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The FESEM and AFM images of unmodified and modified CFE showed distinct
morphological differences on their surfaces. The EDS analysis demonstrated the actual
composition of each compound (Ru and PEDOT) on the surface. As expected EDS
analysis plots (Figure 2.5) indicated a high percentage of sulfur content in the
composition of PEDOT modified electrodes (4000 counts in Figure 2.5 plot C, D)
compared to the unmodified (Figure 2.5 plot a) and Ru-modified electrodes (<500 counts,
Figure 2.5 plot B). Moreover, expected Ru peaks were observed in Ru modified
electrodes as shown in Figure 2.5, plot B and D. Thus, EDS analysis confirmed that the
modified electrodes contained both sulfur from PEDOT and Ru on its surface.
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Figure 2.5. EDS spectra for the (A) unmodified CFE (B) Ru modified CFE (C) PEDOT
modified CFE (D) Ru-PEDOT modified CFE.
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2.3.3 Electrochemical detection

Constant potential amperometry was used to measure NO in a standing solution
using our Ru-PEDOT modified NO sensor. Amperometric detection of NO involves the
oxidation of NO on the surface of the electrode and the measurement of the subsequent
(redox) current generated. Thus, the amount of NO oxidized is proportional to the current
flow at the working electrode. The electrochemical detection of NO in solution occurs at
a positive potential and the process typically involves both electrochemical and chemical
reactions [28].

Figure 6 A illustrates the typical amperometric response of a 7-µm unmodified
CFE and the PEDOT modified CFE upon successive additions of NO in the range of 100
nM - 12.8 µM NO into a stirred, deoxygenated 0.1 M PBS buffer solution at +0.5 V (vs.
Ag/AgCl reference electrode). In this relatively low potential, the modified CFE responds
rapidly to the added aliquots of NO, reaching a steady state current within a few seconds.
A plot of the steady state current vs. the NO concentration for both 7-µm electrodes is
shown in the inset of Figure 2.6 A. The PEDOT modified CFE exhibits significantly
enhanced electrochemical response compared to the unmodified CFE. The sensitivity of
PEDOT modified CFE is ~6.3 pA/nM, compared to the sensitivity of ~0.1 pA/nM for
unmodified CFE.

The increased sensitivity for the PEDOT modified electrode highlights the
importance of sulfur-NO favorable interactions during the NO oxidation process. The
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amperometric response for Ru-PEDOT-Ru modified and unmodified 7-µm CFEs at +0.5
V vs. Ag/AgCl is shown in Figure 2.6 B. The calibration plot shown in the inset (Figure
2.6 B) shows that observed sensitivity for Ru-PEDOT-Ru modified 7-µm CFE is
improved to 15 pA/ nM. When the electrodes were modified with three sequential layers,
the sensitivity increased ~2.5 times compared to the PEDOT modified CFE.
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Figure 2.6. (A) Amperometric responses for 7-µm unmodified CFE (a) and PEDOT
modified CFE (b). (B) Amperometric responses for 7-µm unmodified CFE (a) and RuPEDOT-Ru layers modified CFE (b). The insets are the resulting calibration plot.
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We also investigate the response of NO using 30-µm modified CFEs in the same
manner. The electrode responses for NO modified with PEDOT and Ru-PEDOT-Ru
layers are shown in Figure 2.7 A, B. The sensitivities of PEDOT and Ru-PEDOT-Ru
modified 30-µm are 2.5 pA/nM and 5.7 pA/ nM respectively. As in 7-µm CFE, the
sensitivity for 30-µm LBL modified CFE is improved by ~2.3 fold compared to the
PEDOT modified CFE. The enhanced sensitivity observed at electrodes modified with
three successive layers (Ru-PEDOT-Ru) demonstrates the synergetic effect of conductive
polymer PEDOT as a matrix and electrocatalytic activity of Ru catalyst particles.
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Figure 2.7. (A) Amperometric responses for 30-µm unmodified CFE (a) and PEDOT
modified CFE (b). (B) Amperometric responses for 30-µm unmodified CFE (a) and
Ru-PEDOT-Ru layers modified CFE (b). The insets are the resulting calibration plot.
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The higher sensitivity of both PEDOT and Ru-PEDOT-Ru modified 7-µm CFE,
compared to the 30-µm CFE can be attributed to a better modification process of the
smaller fiber due to faster establishment of radial diffusion profiles during the
electrochemical modification process. Thus, 7-µm CFE modified with Ru-PEDOT-Ru
was used for further characterization and analysis as discussed later. The comparison of
sensitivities and detection limits obtained from modified 7- and 30-µm CFEs are reported
in the Table 2.1. Normalized sensitivities of 7- and 30-µm CFEs are calculated for
comparison purposes. Both PEDOT and Ru-PEDOT-Ru modified 7-µm CFEs showed
~10 fold enhanced normalized-sensitivities than the modified 30-µm CFEs.

Table 2.1. Comparison of sensitivities and detection limits of 7- or 30- µm modified CFE.

Diameter
of the
Sensor
(µm)
7
30

Sensitivity
PEDOT

(pA/nM)
6.3
2.5

RuPEDOTRu

(pA/nM)
14.99
5.7

Normalized
Sensitivity
PEDOT

Limit of
Detection

Ru-PEDOT-Ru
2

2

(pA/nM/µm ) (pA/nM/µm )
1.43x10-4
1.32x10-5

3.40x10-4
3.01x10-5

RuPEDOTRu

250pM
6nM

The detection limit is important when analyzing biological samples and depends
highly on the detection system (chemistry of sensor) employed and the resulting
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sensitivity of the sensor. The sensitivity achieved by our 7-µm CFE modified with RuPEDOT-Ru sensor for lower the concentration range (100-800nM) of NO (Figure 2.8 A)
is 24.46 pA/nM, which is much higher than the sensitivity (14.96 pA/nM) observed in the
higher concentration range (1.0-12.5 µM) (Figure 2.8 B). The high performance of
sensitivity in the low NO concentrations can be explained from the electrocatalytic
behavior of the NO determination and available electrocatalytic sites relative to amounts
of NO. At low doses (low concentration range) saturation of sites is unlikely and the
response is maximum. When the NO concentration is increased, pre-saturation occurs
and the catalytic sites and starts to limit the sensitivity of the electrode.
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Figure 2.8. Current/NO dose plot for 7-µm unmodified CFE and Ru-PEDOT-Ru layers
modified CFE. (A) low NO concentration (B) high NO concentration. Applied potential is
+0.5 V vs Ag/AgCl.

The limit of detection (LOD) is the lowest concentration of analyte that can be
analyzed by the sensor with a significantly low background noise (signal/noise = 3). We
were able to measure NO concentration as low as 250 pM for Ru-PEDOT-Ru modified
CFE as shown in Figure 2.9 with a signal-to-noise ratio of 3. The sensitivity and the limit
of detection obtained with our Ru-PEDOT no sensor show high performance compared to
other reported values in the literature using CFE sensors (we are comparing only surfaces
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of similar geometries to ours). The comparison of sensitivities and detection limits of
similar NO sensors that used polymeric matrices to modify the surface and our sensor are
shown in Table.2.2.

Current/nA

1nA
10s

250pM

Time/s

Figure 2.9. Amperometric response of Ru-PEDOT-Ru layers modified CFE to 250 pM NO
under stirring (250 RPM) pH 7 PBS. Applied potential is +0.5 V vs Ag/AgCl.
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Table 2.2. Comparison of sensitivities and detection limits of few published NO sensors.

Sensor assembly

NO response characterizing

Ref.

Support

Membrane

Potential at which
NO is determined
(reference
electrode)

Carbon (fiber
(cylindrical; diameter
= 7µm length = 2
mm)

Nafion |WPI membrane

0.86 V/Ag-AgCl

1.03 pA/ nM

5 nM

[29]

Carbon (fiber
(cylindrical; diameter
= 8µm length = 2
mm)

Ni-THMPP a|Nafion

0.79 V/Ag-AgCl

6.28 pA/ nM

1 nM

[30]

NiTHMPP|Nafion|AAO b|
poly-lysin

0.7 V/Ag-AgCl

1.34 pC/nM

0.5 nΜ

[31]

Nafion| o-PD c

+0.9 V/Ag-AgCl

31 pC/µM

35nM

Carbon (fiber
(cylindrical; diameter
= 7.8µm length = 0.5
mm

PBPB d|Nafion

0.80 V/Ag-AgCl

1.04 pA/ nM

3.6nM

[32]

Carbon (fiber
(cylindrical; diameter
= 7µm length = 2 mm

Ru| PEDOT| Ru| Nafion

0.50 V/Ag-AgCl

15 pA/ nM

250 pM

This
work

Carbon (fiber
(cylindrical; diameter
= 7µm length = 2
mm)
Carbon (fiber
(cylindrical; diameter
= 30µm length = 2-3
cm)

Sensitivity

Limit of
detection

[7]

a

THMPP = tetrakis-4-hydroxy-3-3methoxyphenylporphyrin,
AAO = Ascorbic acid oxidase;
c
o-PD = o-Phenylenediamine
d
PBPB = Poly bromophenol blue
b
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We also investigated the response of our Ru-PEDOT-RU sensor in flow injection
analysis (FIA) method that leads itself to automated analysis (especially in the clinical
field). The buffer solution was used as the carrier stream in which different NO
concentrations were injected. Our NO sensor (Ru-PEDOT-Ru modified 7-µm CFE) was
used as the working electrode in the FIA system. Short analysis times enabled quick
sample analysis. The significant increase in the peak current observed with modified CFE
clearly confirms the improved sensitivity of the modified electrode (Figure 2.10). The
resulting charge/NO dose response plot (Figure 2.10, inset) shows high sensitivity (0.9
µC/nM) compared to the unmodified CFE (sensitivity is 0.007 µC/nM).
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Figure 2.10. Flow injection analysis response of unmodified (a) and modified (b)
CFE. The inset is the resulting calibration plot. Applied potential +0.5V vs Ag/AgCl.
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We also focused on improving the selectivity of the sensor towards NO for further
applications in biological systems. In fact, NO sensors are practically useless unless they
are immune to interference from other species present in the measured environment.
Selectivity can be achieved by carefully choosing the applied voltage and by using
selective membranes. Since the applied voltage in our case was +0.5 V, which is less
positive than most potentials used for available NO sensors (e.g. compare this to +0.85 V
used for WPI sensors), it was selective for NO in the presence of other species requiring
more positive potentials. By applying such a low potential we could eliminate interfering
nitrite ions from NO detection (Figure 2.11). In addition, with regard to sensor
application in biological systems, using a permeable membrane can provide more
selectivity. Nafion has been extensively employed in the design of many chemical
sensors and biosensors for in vitro as well as in vivo applications [7, 15, 21]. Nafion, a
negatively charged polymer, can be used on the surface of the electrode to prevent
anionic electroactive species from interfering with the oxidation of NO. Figure 2.12
clearly shows the protective action of Nafion coated Ru-PEDOT-Ru modified CFE
against interferences such as L-ascorbic acid, arginine, and nitrite. High concentrations of
interferences were tested and the sensitivities of each compound and the NO: interference
ratios are reported in the Table 2.3.
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10nA

Current/nA

5s

A

50µM NO
2

B
50µM NO
2

Time/s

Figure 2.11. (A) Amperometric response of 7-µm Ru-PEDOT-Ru layers modified CFE
for 50 µM NO2- at the potential of +0.5 V vs. Ag/AgCl (B) Amperometric response of
7-µm Ru-PEDOT-Ru layers modified CFE for 50 µM NO2- at the potential of +0.8 V vs.
Ag/AgCl.
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Figure. 2.12. Amperometric responses of nafion coated Ru-PEDOT-Ru modified CFE to
addition of NO and other interferences (L-Ascorbic acid (L-A.A), Nitrite (NO2-) and LArginine (L-Arg)). Applied potential is +0.5 V vs Ag/AgCl.
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Table 2.3. Interferences of various compounds with the three layers modified sensor.
Tested Concentration

Sensitivity

NO : Interference

(µM)

(pA/ nM)

ratio

Ascorbic acid (AA)

100

1.899 x 10 -2

531:1

NO 3 -

100

1.98 x 10 -5

1400:1

NO 2 -

100

4.19 x 10 -3

1204:1

L-Arginine

100

5.2 x 10 -5

970:1

Compound

2.4 Summary of Chapter II

In this study, we have developed a highly sensitive and selective NO sensor
based on a composite combination of conductive polymer and catalytic transition metal
on CFE. The PEDOT modified 7-µm carbon fiber microelectrode shows high sensitivity
of 6.3 pA/nM, which is ~60 times higher value compared to the unmodified CFE (0.1
pA/nM). On the other hand PEDOT modified 30-µm carbon fiber microelectrode shows
sensitivity of ~3 pA/nM. The modified electrodes give rapid and reproducible response
for NO concentrations at a relatively low applied potential (+0.5 V as compared to +0.8
V or higher for all current commercial probes). The lower oxidation potential is a result
of favorable sulfur-NO interactions.
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Further, the three consecutive layers modification of CFE with the combination
of transition metal catalyst Ru results in higher sensitivity for NO detection (about 6
pA/nM for 30 µm CFE and 15 pA/nM for 7-µm CFE) with excellent linearity (a wide
linear range from nM to µM). The sensitivity of Ru-PEDOT-Ru modified 7-µm CFEs is
enhanced to about 150 times compared to unmodified CFE. In the low range of NO
concentrations, Ru-PEDOT-Ru modified 7-µm CFEs give superior sensitivity (~25
pA/nM) for NO than in higher ranges. As such we achieved a significantly lower value
for the detection limit (250 pM). In addition to a potential-based selectivity (at +0.5 V
nitrite does not interfere), we showed that Nafion membranes could also be used on our
Ru-PEDOT-Ru to prevent anionic electroactive interferents from being oxidized with
NO. Our high sensitive and selective sensor offers great promise for measurement of NO
in biological systems, such as live cells.
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CHAPTER III

DETECTION AND QUANTIFICATION OF NITRIC OXIDE RELEASED FROM
LIVE CELLS

3.1 Introduction

NO is produced by various cell types through activation of the different isoforms
of nitric oxide synthase enzyme in an NADPH dependant pathway. As explained in
chapter I and II, NO plays key roles in various biological systems in a concentrationdependant manner. The fluctuation of NO concentration in biological systems can yield
to a range of disorders. Lower production of NO plays a role in hypertension [1, 2],
impotence [3, 4], hyperglycemia, arteriosclerosis [5, 6], Parkinson's disease, and
Alzheimer's disease [9]. On the other hand, excessive production of NO contributes to
rheumatoid arthritis [10], reperfusion injury [11, 12], septic shock [13], immune type
diabetes [14],

neurotoxicity (associated with aneurysm) [15], and hypotention [16].

Understanding of many biological processes, which are associated with NO function,
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would greatly benefit from the ability to analyze NO release from cells or tissues.
Measurement of NO in intact live cells provides more relevant knowledge of their
physiological function than biochemical assays carried out with purified molecules in test
tubes. Thus, measuring and quantifying the amount of NO production in biological
systems and matrices may be vital in elucidating physiological and pathological
processes related to NO production and release. However, due to low NO concentration
produced in vivo and its high reactivity, the direct detection of NO in biological systems
is a challenging task [17, 18].

Currently

available

analytical

techniques

for

analyzing

NO

include

chemiluminescence, electron paramagnetic resonance (EPR) spectroscopy, combining
capillary electrophoresis (CE) with the detection of laser-induced fluorescence (LIF), and
electrochemisty. As described in chapter I, in the chemiluminescence technique, NO
needs to react with ozone or hydrogen peroxide, which are toxic to cells [19]. Due to the
low special resolution, the EPR method also tends to be disadvantageous for real time
NO measurements [20, 21]. In florescence analysis, increase in florescence inside the
cells is taking account for NO measurements [22-24]. The electrochemical techniques is
easily amendable to use in NO detection in live single cells in real time with sufficient
special and temporal resolution.

In the recent bioscience research environment, the usefulness and versatility of
cellular analysis has gained great interest. A number of indirect methods are available to
detect NO at the single cell level by analyzing reactants, cofactors, and products of NOS
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reaction. However, electrochemical methods provide simple and sensitive approaches
that can be applied at the cellular levels. In this work we discuss the use of our RuPEDOT-Ru modified electrochemical sensors to monitoring NO released from mouse
embryonic fibroblast cells as well as from an isolated single human umbilical vein
endothelial cells.

3.2 Experimental Section

3.2.1 Chemicals and reagents

Mouse embryonic fibroblast cell culture (NIH/3T3) and human umbilical vein
endothelial cells (HUVEC) were obtained from (ATCC, VA, USA). Dulbecco's modified
Eagle's medium with L-glutamine, glucose, and sodium bicarbonate (DMEM), trypsin,
with EDTA solution, and F-12K medium were obtained from LRI Cleveland Clinic,
Cleveland. Bovine calf serum, heparin, endothelial cell growth supplement (ECGS), and
fetal bovine serum were purchased from (Sigma-Aldrich, St Louis, MO).

3.2.2 Materials and Apparatus

All the materials for electrochemistry are used as indicated in section 2.2.1 and similar
experimental setup and instrumentation is used as outlined in section 2.2.2. Cell
experiments were carried out on the stage of Olympus IX 71 inverted microscope, Center
Valley, PA.
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3.2.3

Cell Culture Preparation

Mouse embryonic fibroblast cell cultures (NIH/3T3) were grown in Dulbecco's
modified Eagle's medium with 4 mM L-glutamine, 4.5 g/L glucose, 90% bovine calf
serum and adjusted to contain 1.5 g/L sodium bicarbonate. The medium was renewed
every 2 days until confluence (4-5 days) and cell cultures were split in small dishes (35 x
10 mm). The cells were then rinsed with 0.25% (w/v) trypsin 0.53 mM EDTA solution
and detached by incubating in trypsin-EDTA for 5-10 minutes at room temperature. The
cell suspensions were then transferred to new cell culture dishes and allowed to grow at
37 oC in the presence of 5% CO2 in a humidified environment. Cells were washed with
PBS buffer and experiments were performed in PBS at room temperature.

Human umbilical vein endothelial cells (HUVEC) were grown in F-12K medium
and 0.1 mg/ml heparin and 0.03-0.05 mg/ml endothelial cell growth supplement (ECGS)
were added to the base medium and adjusted to a final concentration of 10% fetal bovine
serum.

3.2.4 Cell Experiment Setup

The experimental setup for cell stimulation is shown in Figure 3.1. Prior to the
experiment, the culture medium is removed and adherent cells are incubated with PBS
buffer solution. Our NO microsensor (Ru-PEDOT modified carbon microfiber) is
positioned 10-15 µm above the cell surface with the use of a micromanipulator attached
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to the stage of an inverted microscope. A potential of +0.5 V vs. Ag/AgCl is then applied
to the NO sensor. Once a steady background current is obtained, the stimulator is injected
near the cells to stimulate the NO synthesis and release. Figure 3.2 shows a sketch of the
setup near a cell surface and shows NO released in the microvolume above the cell and
its capture at the electrode surface.

.
Figure 3.1. The experimental setup used for cell analysis.
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Figure 3.2. Sketch showing the fate of NO released from cells, into a
micro-volume of buffer solution and its capture by oxidation at the
NO-sensor. Adapted from ref. [8] .
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3.3 Results and Discussion

3.3.1 NO released from mouse embryonic fibroblast cells

The potential role of mouse embryonic fibroblast cells in nonspecific host defense
and inflammation can be evaluated by analyzing the pathways that regulate NO
production [16]. Lipopolysaccharide (LPS) and IFN-γ are major activators of the
transcription factor NF-κB, which plays a pivotal role in the regulation of the inducible
NOS (iNOS) gene expression induced by inflammatory mediators [25].

Analysis of NO production in fibroblasts may provide an understanding of their
potential role in host defense and inflammatory disorders. Indirect measurements of NO
in mouse fibroblasts have been reported and involve mainly nitrite quantification [16]. In
this work, we investigate the capability of using our sensor to detect NO released from
stimulated mouse fibroblasts. The bacterial endotoxin LPS is used as the stimulant due to
its ability to activate the iNOS-signaling pathway. LPS is a large molecule consisting of a
lipid and a polysaccharide part (carbohydrate) bound together with covalent bond as
shown in Figure 3.3.
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Figure 3.3 The shamatic diagram showing the structure of
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The iNOS expression cascade upon stimulation with LPS and IFN-γ in
macrophage-like cell-lines is represented in Figure 3.4. LPS and IFN-γ have synergistic
effect on iNOS expression. Onced expressed, iNOS converts L-arginine to L-citrulline
and NO.

As described in section 3.2.3, the NO microsensor is positioned 5-10 µm above
the surface of collection of cells. Once a steady background current is obtained, 50 μg/ml
LPS is injected near the population of cells (5.0 x105 cells/ml) to stimulate NO synthesis
and release.
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After carefully injecting 50 µg/ml of LPS close to the cells, the changes in current
signal were monitored as a function of time. A typical current-time plot obtained is
shown in Figure 3.5. We observed a change in current immediately after the addition of
LPS. To make sure that the NO released comes from LPS-induced iNOS cascade, the
cells were treated with non-specific nitric oxide synthase (NOS) inhibitor, NG-nitro-Larginine methylester (L-NAME) (shown in Figure 3.6), prior to the experiment. The LNAME inhibits the synthesis of NO by blocking the active site of iNOS.
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Figure 3.5. Amperometric response of our NO sensor after stimulation of
NO synthesis by addition of LPS to the mouse embryonic fibroblast cell
culture.
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Figure 3.6. Structure of nitric oxide synthase (NOS) inhibitor, NG-nitro-Larginine methylester (L-NAME).
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Control experiments were carried out to confirm that the response observed in
Figure 3.6 is due to NO released from fibroblast cells. To check that the injection process
itself does not cause the current change, an equivalent volume (100 µl) of phosphate
buffer (PBS) is injected into the solution close to the cells in lieu of LPS; no significant
change in the background current is observed, Figure 3.6. As such, cells were treated with
L-NAME prior to LPS stimulation; as shown in Figure 3.7, no response in current was
observed after LPS stimulation. Another control experiment was carried out to check
whether the current observed is a result of mere redox activity of LPS. As shown in
Figure 3.8, there was no response of the current when LPS is injected into buffer solution
in the absence of fibroblast cells. Figure 3.9 summarizes the responses of the NO sensor
after addition of LPS to the collection of cells, L-NAME treated cells, and to the buffer
solution.
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Figure 3.7. Amperometric response of our NO sensor after addition of
LPS to the cell culture before and after L-NAME inhibition.
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Figure 3.8 Amperometric response of our NO sensor after addition of LPS to
the PBS solution.
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Figure 3.9. Amperometric response of our NO sensor after addition of LPS to the
cell culture (A) L-NAME pretreated cells (B) and buffer solution. (C).
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Together, these experiments and controls confirm that the response of the
electrode observed after LPS stimulation of the fibroblast cells is due solely to the
oxidation of NO released from the cells.

After cell analysis, the Ru-PEDOT-Ru NO sensor was calibrated in the same
experimental conditions, by adding NO standard solutions in situ as detailed previously
(Chapter II, section 2.3.3). The sensitivity achieved for NO concentration ranges of 0.01
µM to 0.4 µM is 17.58 pA/nM (shown in Figure 3.10). The sensitivity of electrode in
open system is slightly lower compared to the closed, deoxygenated system (24.46
pA/nM) (Chapter II). The maximum current measured was equivalent to a local NO
concentration of 17 ± 6.3 nΜ (n=5) after stimulation of fibroblast cells by LPS.
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Figure 3.10. Current/NO dose plot for 7-µm Ru-PEDOT-Ru layers modified CFE
in cell experiment conditions. Applied potential is +0.5 V vs Ag/AgCl.
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3.3.2. NO released from Human Umbilical Vein Endothelial cells (HUVEC)

The endothelium that lines the interior surface of blood vessels acts as a highly
specialized, metabolically active interface between blood and the underlying tissues; it
also maintains vascular tone, counteract platelet adhesion, and immune response. The
vascular endothelium responds to various agonists and shears flow by producing nitric
oxide [26-28]. The endothelium NO production is catalyzed by a constitutive enzyme
called endothelial NOS (eNOS). The change in NO production from eNOS may cause
significant effects in biological functions and can signal the onset of various pathological
states. Endothelial dysfunction, which is associated with deficiency of NO, occurs in
hypertension, ischemia, diabetes, and stroke [29]. As pointed out earlier, high
concentration of NO in biological systems is a feature of septic shock and hypotension. It
is important to measure and quantify the NO production in biological matrices to
elucidate the physiological and pathological processes related to NO production and
release.

Our Ru-PEDOT-Ru modified NO microsensor was used to monitor NO released
from HUVEC by stimulating them with bradykinin. Bradykinin, shown in Figure 3.11, is
an endogenous vasodilator formed of nine amino acid residues released from plasma
globulins called kininogens. It can form locally in injured tissue, act in vasodilation of
small arterioles, and is considered to play a part in inflammatory processes.
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Figure 3.11. The structure of bradykinin.

Different agonist such as acetylcholine, bradykinin, and histamine can activate
the endothelial NOS (eNOS) via a calmodulin-dependent pathway. The increase in
intracellular Ca2+ concentration causes the release of NO within a second upon
stimulation [30]. Endothelial NOS stimulation pathway is shown in Figure 3.12.
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Figure 3.12. Substrate and cofactor requirements for nitric oxide (NO)
synthase activation [31].
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NO

HUVEC cells (4.8 x 105 cells/ml) are incubated with PBS buffer solution and our
NO microsensor is positioned as explained in part 3.1.4. The background current is then
allowed to stabilize at an applied potential of +0.5 V vs. Ag/AgCl. NO release is
stimulated using bradykinin, which is injected in the vicinity of the cell surface.

Figure 3.13 shows the amount of bradykinin-response curve of the NO release.
The current response gradually increased when the amount of bradykinin increased from
0.1-0.5 µmol. A plateau was reached at the amount of bradykinin higher than 0.5 µmol.
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Figure 3.13. Current-response for NO released from HUVEC with
different amounts of bradykinin stimulation.
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The concentration of NO released by varying the bradykinin amount is shown in
Figure 3.14. Since there is no change in current response (and NO release) with amounts
of higher than 0.5 µmol bradykinin, this amount was used for the stimulation processes.
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Figure 3.14. Change in concentration of NO released with the varying
amount of bradykinin.
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Injection of 0.5 µmol of bradykinin near the HUVEC cell surface induces a rapid
and transient redox current reaching a peak within 20 s, Figure 3.15. Addition of 0.5µmol
bradykinin increased the local NO concentration at the surface of collection of cells to
nearly 300 nM, with maintenance of these high NO levels for ~2 min. This response is
typical even when cells were repeatedly stimulated with bradykinin.

25nA

Current /nA

50s

0.5 µmol Bradykinin

Buffer

Time/s

Figure 3.15. Amperometric response of our NO sensor upon addition of
bradykinin to HUVEC cells.
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As a control, injection of a phosphate buffer close to the cells does not result in a
significant change in the background current (Figure 3.15). Similarly, the typical peak
response is not observed when bradykinin is injected into buffer solution in the absence
of the cells, Figure 3.16. Another negative control was performed in the presence of the
NOS inhibitor, L-NAME. Incubation of the HUVEC cells with L-NAME for 5-10
minutes prior to bradykinin stimulation shows no significant change in background
current at our NO microsensor as shown in Figure 3.17. Together, these results suggest
that the observed current change is due to the oxidation of the NO released from the cells.

Current /nA

40nA
50s

0.5µmol bradykinin

Time/s

Figure 3.16. Amperometric response of our NO sensor upon addition of
bradykinin to the buffer solution in the absence of cells.
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0.5µmol Bradykinin
0.5µmol Bradykinin

0.5nmol L-NAME

Time/s

Figure 3.17. Amperometric response of our NO sensor upon addition of
bradykinin to HUVEC cell culture before and after L-NAME inhibition.
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3.3.3 NO detection in an isolated single Human Umbilical Vein Endothelial cells

Measurement of local NO concentration at a single endothelial cell is of particular
interest in order to understanding the development and progress of NO-related diseases.
Measuring analytes released from live single cells is critical to gaining fundamental
understanding of many biological functions. Because of trace amount of NO produced by
single cells, highly efficient, sensitive, and selective detection methods are necessary. In
this regard, we investigated the performance of our modified sensor for NO detection and
quantification at the level of live single human umbilical vein endothelial cell (HUVEC).

The amperometric response of our NO microsensor upon stimulation of single
HUVEC cells by bradykinin is shown in Figure 3.18. The bradykinin stimulation of an
isolated single cell changed the baseline current by giving 1.97 ± 0.53 nA, which is much
less than the change in current observed for a population of cells (ca. 15 nA). Control
experiments similar to what was described for the collection of cells were also performed.
The response is consistent with the amount of NO released from a single cell as
compared to a collection of cells. The NO amounts calculated using Ficks’ law shows the
~14.0 attomoles (n=6) of NO produced by a normal single HUVEC cell upon bradykinin
stimulation under the conditions described (the detail calculation is repoted in next
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section). While the current change recorded is small, it can still be accurately measured
with our highly sensitive NO microsensor.

2.5nA
PBS without cells C

25s

0.5µmol Bradykinin

L-NAME treated cells B

0.5µmol Bradykinin

Cells in PBS

A

0.5µmol Bradykinin

Figure. 3.18. Amperometric response of our NO sensor upon addition of bradykinin to
an isolated single cell (A) Same as (A) but with L-NAME pretreated cells (B) Same as
(A) but in the absence of cells to the buffer solution (C).
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Appendix. Calculation of the amount of NO released from isolated single cell

The theoretical NO diffusion profile from a single cell surface is shown in scheme
3.1.

Scheme. 3.1. Schematic diagram showing the NO diffusion from a cell surface.

The amount of NO released from a single cell can be calculated using EinsteinSmoluchowski diffusion equation [32] as shown in equation 3.1.

2Dtmax = δ2

Equation 3.1

Where D is the diffusion coefficient, tmax is the time and δ is the radial distance from the
cell surface.
The following assumptions are used in our calculations:
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(i) Diffusion and resulting diffusion currents are governed by Fick's Laws (i.e. only
concentration gradients are involved).
(ii) The diffusion coefficient of NO is constant and not a function of concentration or
distance. From the experiment, time (tmax) is known and the diffusion coefficient of NO
(DNO) is reported [33] as 3300 µm2s-1 hence, the distance from the cell surface can be
calculated. Using the diffusion distance (δ), one can derive the maximum diffusion
volume of NO (½Vmax).

2Dtmax = δ2
Mean DNO = 3300 µm2s-1
δ

= (2DNOtmax)1/2 = (2 x 3300 µm2s-1 x 50s)1/2

δ

= 0.5 x 10-3 m

Vmax = Vtotal – Vcell
Where, Vtotal is the total volume and the Vcell is the volume of cell.
Based on the typical HUVEC dimentions;
Vmax = (4/3)*π (0.5 x 10-3 m + 5x10-6m)3 - (4/3)* π (5x10-6m)3
Vmax = 2.722 x 10-13 m3
½Vmax = 1.36 x 10-13 m3
The diffusion volume of NO released from the single cell is therefore: V = 1.36 x 10-10 L
The average current response = 1.97 ± 0.53 nA (n=6); our standard calibration curve in
the same experimental conditions gives a corresponding NO concentration of ~0.1µM;
therefore the number of moles of NO is captured at the electrode surface is:
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moles NO = 0.1 x 10-6 molL-1 x 1.36 x10-10 L
= 13.6 x 10-18 mol
= ~14.0 attomoles

It is a great advantage to know the range of NO amounts produced in normal
endothelial cells to identify the diseases in early stages that are associated with NO [29].

3.4. Summary of Chapter III

The results demonstrate that the performance of our Ru-PEDOT-Ru NO sensor
is great for quantitative and real-time analysis of NO release from live cells. The NO
sensor allowed us to monitor NO synthesis and release from cultured mouse embryonic
fibroblast cells, cultured human umbilical vein endothelial cells (HUVEC), and from
single HUVEC cells. The calculations show the amount of NO released from an isolated
healthy HUVEC is ~14.0 attomoles, which may be used as the set value for the early
determination of disease status that correlates with NO. These direct analysis
performance of the modified NO sensor allows us to measure NO released from NOS
entrapped in liposomes as described in Chapter IV.
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CHAPTER IV

THE NOS-LOADED LIPOSOME AS A PLATFORM FOR THE TREATMENT
OF NO/NOS DEFICIENT TARGETS

4.1. Introduction

As explained in Chapter I, nitric oxide (NO) is an extremely important and
versatile messenger in the biological system. At first, it was recognized as an
endothelium-derived relaxing factor in the vascular system [1]. It has also been identified
as a neurotransmitter or neuromodulator in the neuronal system [2] and a cytotoxic factor
in the immune system [3, 4]. In addition, it is believed to be that NO is related to some
tissue damage, such as ischemia/reperfusion tissue damage [3, 5] and excitatory neuronal
death [6-8].
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Nitric oxide is produced from the guanidino group of L-arginine in an NADPHdependent reaction catalyzed by a family of nitric oxide synthase (NOS) enzymes [9].
There are three distinct isoforms of NOS: neuronal NOS (nNOS), inducible NOS (iNOS),
and endothelial NOS (eNOS) [10]. All three NOS isoforms have a similar molecular
structure and require multiple cofactors, including flavins (FMN,FAD), NADPH, and
tetrahydrobiopterin (BH4) that are required to maintain the active dimeric form of the
enzyme.

As described in previous chapters, NO is involved in many important
physiological processes. Although the remedy for circumstances with insufficient NO
production is a supply of NO to targets, it is not feasible because of the short lifetime and
high reactivity of NO in biological systems. Thus, the treatment with NOS delivery to the
targets is a promising method to overcome NO deficiency. NOS gene delivery has been
reported for several years to cure NO deficiency. The deficiency of NO production in the
cardiovascular system is an early aspect of atherosclerosis and other vascular injury [11].
Since the amount of NO plays an important role in phathogenesis of above diseases,
eNOS gene transfer has a potential as a therapeutic strategy for treatments [12, 13]. NO
produced by iNOS is responsible of angiogenesis [14, 15] and endothelial and epithelial
cell proliferation and migration, which is associated with the wound healing [16-18]. To
promote wound healing in NO deficient states, iNOS gene transfer showed some
potential as a strategy [19].
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Despite the fact that the NOS gene therapy shows prospective benefits, several
obstacles have to be defeated for the clinical practice. The foremost concerns of NOS
gene therapy are the limitations of currently available vectors, the need of suitable
delivery methods to targets, and the difficulties of control of the NOS expression. To
surmount those problems associated with gene therapy, delivery of NOS enzyme itself to
targets may provide alternative routes for temporary remediation of NO deficiency.

Liposomes are considered as effective delivery systems owing to their unique
properties. Liposomes were first described by Alec Bangham in 1965 while studying cell
membranes. He found that lipsomes are vesicular structures consisting of hydrated
bilalyers, which form spontaneously when phospholipids are dispersed in water. At that
moment in time, neither the name nor their eventual efficacies as drug carriers were
recognized. Ever since, further studies into liposomes and their relevance in diverse areas
such as medicine and research have been explored. The question was whether these lipid
structures were closed membranes bearing similar properties as biological cell
membranes. As the most copious lipids in the cell membrane, phosphotidylcholine
received much attention in the studying of cell model system formation. Subsequently,
the liposome research area was extended to several other lipids, such as cholesterol and
sphingolipids.

The most important quality of liposomes is the ability to enclose an aqueous
medium separate from the external aqueous medium. Since liposomes are formed with
lipid bilayer membranes that are identical to the natural cell membrane, they are
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considered a simple-model system to study cellular properties. Liposomes encapsulate an
aqueous solution inside a hydrophobic membrane. Dissolved hydrophilic solutes cannot
readily pass through the lipids. This property makes liposomes more effective
biocompatible carriers in the development of delivery systems. Hydrophobic compounds
can be dissolved in the membrane, and, in this way, liposomes can carry both
hydrophobic molecules as well as hydrophilic molecules. To deliver the molecules to
sites of action, the lipid bilayer fuses with other bilayers, such as the cell membrane, and
liberate the liposome contents.

The encapsulation of proteins in liposomes has gained great interest.
Encapsulation provides stabilization and it prevents denaturation and proteolysis of
proteins inside the liposome. Thus, as explained in Chapter I, liposome with encapsulated
is a promising approach in carrying and delivering protein to targets for medical and
pharmoceuticle perspectives. The aim of this study is the investigation of the efficacy of
liposomes for carrying NOS enzymes and preserving their native structure and function
for potential delivery to targets deficient in NO. To this end, conventional and NOSembedded liposomes will be evaluated. NOS-loaded liposomes will be prepared by
means of the thin-film hydration method in the presence of the target enzyme. The mild
operative conditions allow the preservation of enzymatic structural integrity and activity.
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4.2 Experimental Section

4.2.1 Materials

1,2-distearoyl--glycero-3-phosphocholine (DSPC) was obtained from Avanti
Polar Lipids (Alabaster, Alabama). Cholesterol, Trizma base, K3PO4, KH2PO4, MgSO4,
EDTA, Triton-X, and glycerol were purchased from Sigma-Aldrich (St Louis, MO).
Nanopure deionized water (specific resistance >18.2 MΩ.cm) used is supplied by a
Barnstead water purification system model D8961. All chemicals are reagent grade and
used as received. Bradford assay kit for protein analysis was obtained from Bio-Rad
Laboratories (Hercules, CA). The Griess assay kit was purchased from Promega
(Madison, WI).

4.2.2 Apparatus

Amperometric measurements are carried out using the CHI-440 electrochemical
workstation. Electrochemical experiments of NOS-loaded liposomes are carried out on
the stage of an Olympus IX-71 inverted microscope (Center Valley, PA) with the
microelectrode positioned 10-15 µm above an isolated single liposome. The
micropositioning was done with the help of a micromanipulator. An atomic force
microscope (AFM) (Molecular Imaging Corp, Tampe, AZ) was used for characterizing
the liposomes. Buchi Rotavapor from Buchi Corporation (New Castle, DE) was used for
the evaporation. A mini-extruder obtained from Avanti Polar Lipids (Alabaster, Al). The
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average particle size of vesicles was obtained by dynamic light scattering (DLS) using a
90 plus particle size analyzer, Brookhaven Instruments Corporation (Holtsville, NY).
UV-visible absorbance spectra were recorded on an Agilent 8453 spectrophotometer
using 1-cm path UV-visible cells.

4.2.3 Liposome Preparation

Liposomes are obtained by the thin-film hydration method followed by an
extrusion process through a 10 nm pore size membrane [20]. Briefly, phosphatedyl choline lipids (PC, 5 mg) and cholesterol (0.5 mg) are diluted with chloroform to a lipid
concentration of 10 mg/mL. This solution is transferred to a round-bottom flask and the
solvent is removed on a rotary evaporator for ~6 h at room temperature to form a dry,
thin lipid film on the walls of the flask. To this film, a PBS buffer (Trizma base 5 mM,
K3PO4 30 mM, KH2PO4 30 mM, MgSO4 1 mM, EDTA 0.5 mM, pH 7.4.) containing 1%
v/v glycerol is carefully added to a lipid concentration of 5 mg/mL. The lipid film is
allowed to swell overnight at 4 ° C. Finally, the sample is subjected to 10 freeze thaw
cycles in liquid nitrogen and warm water. The unilamellar vesicles are then extruded
through 0.1 µm pore-size polycarbonate filters to obtain liposomes with uniform-size.
The unilamilar vesicle (UV) suspension is then stored at 4 °C for several days.
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4.2.4 NOS encapsulation in liposomes

The thin lipid film is further dried by flowing dry nitrogen gas into the flask and
ensure complete evaporation of the organic solvent. An aqueous solution of iNOS (or
other isoforms) enzyme (0.45 µM) is then used to hydrate the lipid film before dilution
with a pH 7.4 buffer solution. In order to eliminate unencapsulated NOS protein, the
liposome suspension is passed through an activated Ni2+ column, which traps only the
free histidine-tagged NOS proteins. The fractions containing NOS-encapsulated
liposomes are collected and used for further analysis.

4.2.5 Size determination and the stability of NOS-loaded liposome
The mean liposome diameter and the size distribution of the vesicles were
determined by dynamic Light Scattering (DLS). A 20 µl portion of the liposome
dispersion was diluted with 1 ml of filtered buffer solution (0.2-µm pore size
polycarbonate filters) and measurements were made at 25 oC.

The stability of the

liposome dispersion upon storage at 4 o C was monitored periodically by DLS.
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4.2.6 Visualization of NOS inside the liposome

4.2.6.1 Formation of Ni-NTA-Gold tag NOS

Ni-NTA-Gold and His-taggged protein in TBST (20 mM Tris, pH 7.6, 150 mM
NaCl and 0.05 % Tween 20) were mixed together in 10:1 molar ratio. The mixture was
kept at room temperature for 2 hours and then centrifuged to remove unlabeled Ni-NTAgold by reducing the volume to 0.05 ml using 50,000 cutoff centricon (Millipore Amicon
Ultra-4; 50 kD). The above step was repeated three times and the modified protein was
collected in TBST and stored at –4 o C.

4.2.6.2 Gold enhanced (EM) Ni-NTA-Gold labeled NOS

The gold labeled NOS suspension was concentrated using centricon, and then
redissolved in 3 ml deionized water followed by centrifugation to reduce the volume to
0.05 ml. The gold enhancement (20µl of each solution) was added to the protein mixture.
After 5 minutes, the gold-labeled proteins were centrifuged at 35000 g. The gold-labeled
proteins were rinsed five times with water by resuspension, in 1.5 ml water followed by
removing the supernatant. The labeled proteins were redissoved in buffer solution and
used as the rehydating medium on dried lipid film for formation of liposomes containing
labeled-NOS.
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4.2.7. Bradford Assay procedure

The total amount of NOS encapsulated was determined by the difference of NOS
in liposome suspension and NOS inside the liposomes. The liposome suspension was
treated with Triton X-100 (10% w/v aqueous solution) at 37 oC. The vesicle/Triton
mixture was subjected to brief sonication to disrupt and empty liposomes of protein
content. The vesicle debris was separated by centrifugation at 4000 rpm for 15 min. The
supernatant was collected and analyzed for protein content by the Bradford microassay
reading the purple complex at 595 nm.

4.2.8. Griess Assay procedure

The Griess assay reagent kit was used with the instruction provided. Briefly, the
NADPH-treated 100 µl of NOS-loaded liposome sample was incubated with 100 µl of
sulfanilamide for 10 minutes in the dark followed by 10-minute reaction with 100 µl N-1napthylethylenediamine dihydrochloride (NAD) in the dark at room temperature. The
absorbance was recorded at 540 nm.

4.2.9 Measuring of the NOS activity in liposomes

The enzyme activity of NOS-encapsulated liposomes was determined by the
detection of NO released upon stimulation by NADPH using our modified sensor. All the
materials for electrochemistry were used as indicated in Section 2.2.1. Similar

126

experimental set-up and instrumentation were used as outlined in the Section 2.2.2. The
NOS-loaded liposomes were incubated with a PBS buffer solution. A micromanipulator
attached to the stage of an inverted microscope allowed us to position the NO-selective
micro-sensor 10-15 µm above the liposome surface as previously shown in Figure 3.4. A
potential of +0.5 V vs. Ag/AgCl is typically applied to our NO-sensitive electrode. Once
a steady background current is obtained, 150 μM of NADPH was injected into the
vicinity of an isolated single liposome surface to stimulate NO release.

4.3 Results and Discussion

4.3.1 Characterization of Liposomes

4.3.1.1 AFM images of Liposomes

Atomic force microscopy (AFM) enables the direct visualization of liposomes and
their morphological structure on mica surfaces in liquid and partially dry samples. The
shape of the liposome depends on the time between the deposition of the sample on a
mica surface and the imaging. AFM images obtained immediately after the deposition
have spherical shapes as expected for lipid vesicles. After some time in air, we observe a
shortening of the lipid vesicular height with broader diameters giving disk-like
appearances as shown in Figure 4.1.

The composition and size of the liposomes

influence both the adsorption onto the mica layer and the vesicle deformation. Most of
the observed liposomes in Figure 4.1 show a structure with an outer deformed layer,
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probably associated with a flattened spherical vesicle. However, the central part of
vesicles still hold and did not rupture.

The most common structure corresponds to a liposome formed by the aggregation
of multiple vesicles as seen in Figure 4.2. Aggregation occurs when a larger vesicle is
formed from the joining of two or more smaller vesicles. During the adsorption process,
the liposome formed by the aggregation of various vesicles has the lower part of its
structure in contact with the mica substrate. Due to mica-liposome interaction, the bottom
part of the structure may be partially open with stronger interaction with the surface,
resulting in the formation of a flattened bilayer that adheres to the surface. The
aggregated liposome structure has to be considered when developing liposomes to be
applied to the field of drug delivery systems since the selective permeability is
substantially modified in aggregated vesicles when compared to single spherical ones.
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Figure 4.1. Representative AFM images of liposomes on mica
surfaces.

Figure 4.2. Three-dimensional images of the typical aggregated
vesicle formed from multiple liposomes.
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4.3.1.2 Microscopic images of Liposomes

The morphology of NOS-loaded giant liposomes can also be routinely observed
under an inverted microscope immediately after the preparation. Figure 4.3 shows large
NOS-loaded vesicles with an average size of 1µm diameter (before being subjected to the
extrusion that reduce their size).

Figure 4.3. Inverted microscope images of large liposomes.
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4.3.2 Size determination and the stability of NOS-loaded liposome

The size distribution of the vesicles was determined by Dynamic Light Scattering
(DLS). In this technique, the Brownian motion of liposomes influence the scattering of
laser light that corresponds to measure of diffusion coefficient, which can be used to
calculate the diameter of liposomes. Homogeneous size distribution of vesicle suspension
is achieved by performing sequential extrusions at moderately low pressure through
polycarbonate membranes with desired pore size.

DLS analysis of liposomes immediately after preparation shows monodispersed
vesicles with the mean size of about 140 ± 30 nm (polydispersity index of less than 0.1)
((Figure 4.4).

Figure 4.4. Size distribution for vesicles in suspension measured in DLS.
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Monitoring of the size of liposomes is a great advantage and it can be reflect on
the stability of liposomes. The size characterization and the stability of liposomes have
the foremost effect of their fate (such as the application and the targets that liposomes can
be used for). Therefore, formation of predictable and reproducible particle size
distribution in each batch of liposomes is a great importance for medical applications.

NOS-loaded liposomes were stored at 4 oC and the stability as a function of time
storage was tested using DLS analysis. The liposome stability was obtained by the
diameter of vesicles as a function of time and is reported in Figure 4.5. The first 15 days
demonstrate an excellent stability of vesicles, and after 30 days the mean diameter of
vesicles increased by around 1.2 fold. The results reveal that liposomes tend to fuse and
aggregate each other as a function of storage time in 4 oC. At the point of 30 days, the
vesicle dispersion was heterogeneous with an increasing polydispersity index (more than
1.0) that pointed out wider diameter vesicles.
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Figure. 4.5. Mean size variation of liposomal suspension as a function
of time.
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4.3.3. Visualization of NOS inside the liposome

The histidine tage has an extremely high affinity for metal ions, which can be
employed

to

purify

His-tagged

protein

by

immobilized

metal

ion

affinity

chromatography. The nickel is chelated to nitrilotriacetic acid (NTA), and histidine
resides in protein make a stable, six-coordinated octahedral compound. NTA can bind
specifically to nanogold particles and therefore used to label His-tag proteins as shown in
Scheme 4.1. Since the Ni-NTA group is quite small compared to an antibody, the gold
particle can reach more closely the 6-His-tag site and give high resolution labeling with
less ambiguity or floppiness. Another advantage of this type of label is the size
compatibility of Ni-NTA group with cells and tissues, which can diffuse more easily
[21]. The nanogold-labeled protein can be visualized by an electron microscope for
higher resolution studies; it can also be visible with a light microscope after treatment
with gold enhancement.
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Scheme. 4.1. The diagram of His-tagged protein and Ni-NTA-Nanogold complex
Adapted from ref. [21].

Ni-NTA-nanogold was used as a tool for localizing and visualizing His-tagged
nitric oxide synthase enzyme inside liposomes. The NOS protein was first modified with
Ni-NTA-nanogold group, and, after gold enhancement, the modified NOS was loaded
inside the liposome.

Liposomes enclosed with gold labeled proteins were visualized under a
microscope. Darker membranes and darker hollow surfaces were observed under the
magnification of 400X as shown in Figure 4.6. The liposomes loaded with labeled NOS
were much darker compared with the unlabeled NOS-loaded liposomes, which indicate
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that the NOS enzyme is successfully entrapped inside the hollow surface and the
membrane of liposome.

200nm

Figure. 4.6. Microscopic image of NOS-Ni-NTA-Gold loaded liposome.
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4.3.4 Protein content inside the liposome

For liposomes to be a feasible pharmaceutical delivery system, not only the
liposome stability but also the encapsulation efficiency or the loading capacity also needs
to be considered. The total amount of NOS encapsulated was determined either in the
supernatant or in liposome suspensions. Figure 4.7 shows the absorbance vs. wavelength
plot using the Bradford assay and the resultant calibration plot is presented in Figure 4.8.
The encapsulation efficiency (%) of liposomes is defined as the ratio of the total
encapsulant in the liposome and the total initial input of the encapsulant is shown in
equation 4.1 [22].

Encapsulation efficiency (%) = NOS in vesicles
Total NOS added
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Equation 4.1
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Figure 4.7. The absorbance vs. wavelength curve for the standard for
the Bradford protein assay.
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Figure 4.8. The calibration plot for Bradford protein assay.
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Table 4.1 The values obtained from Bradford assay.
Sample

∆Absorbance

[Enzyme] (µg/ml)

NOS*

0.5354 ± 0.2

8.064 ± 2.3

NOS-loaded
Liposome(intact)
NOS After liposome
disruption

2.279 x 10-2

~0.00

0.3187 ± 0.28

2.993 ± 2.1

NOS* - Input NOS concentration after subtracting the unloaded NOS.

Five replicate experiments were used determining the encapsulation efficiencies.
The % encapsulation efficiency for NOS-loaded liposomes was obtained as 40 ± 25%.
The loading capacity remains constant over 15 days upon storage in 4 oC. After 15 days
low loading capacity of the enzyme observed and indicates the vesicle disruption and
aggregation. instability of the vesicles.

4.3.5 Quantification of NO production (NOS activity) using the Griess Assay

The Griess assay is commonly used for the detection of NO synthesis from NOS
and hence can determine the NOS turnovers [23, 24]. In the Griess assay, the nitrite, the
steady breakdown product of NO, is quantified. The Griess reaction is based on the
reaction of nitrite with sulfanilamide under acidic conditions to form diazonium cation.
This cation then couples with N-1-napthylethylenediamine dihydrochloride (NED) to
form a purple azo dye with maximum absorbance at 540 nm [25]. The calibration curve is
constructed using standard nitrite using the same reaction conditions (Figure 4.9).

139

0.4

Absorbance at 540 nm

R2= 0.996
0.3

0.2

0.1

0.0
0

2

4

6

8

10

2

Concentration of NO (µM)

Figure 4.9. The calibration plot for the Griess assay.

Table 4.2 The values obtain from the Griess assay.
Sample

Absorbance

Concentration of NO
(nM)

NOS *

0.0639

1.519 x 103

NOS-Loaded liposome

0.0517

1.153 x 103

NOS*- Input NOS after subtracting unloaded NOS
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According to the Griess assay results, each batch produces 3.5 µM of NO (with
consideration the dilution factor of 3). Compared to the initial protein activity, the
percentage of the protein activity inside the liposomes is 75.91% (n=3). The high % value
demonstrates the retaining of the NOS activity is mostly retained inside the vesicles.

4.3.6 Dynamic measurement of NO released by NOS-loaded liposomes using the NO
sensor

The detection of NO released by stimulated NOS-encapsulated liposomes enables
us to determine the NO release capability activity of NOS enzymes entrapped in
liposomes. If NO synthesis and release is to be triggered within an isolated single NOSloaded liposomes we expect a change in current signal as a function of time after addition
of NADPH. This is indeed what is observed as indicated in Figure 4.10. The sharp drop
in current signal after the addition of 45 nmol of NADPH is due to the oxidation of NO
released from single NOS-encapsulated liposome. In fact control experiments (e.g. the
addition of 10 µl of buffer solution to NOS-liposomes) do not give this positive
responses, as shown in Figure 4.10. Each NOS-loaded liposome produced a 19.8 nM
concentration of NO. Since liposomes are spherical, they can be considered as cellmimics. Using similar calculations as in (Section 3.3.4), the amount of NO produced
from one liposome is around 3.7 attomoles and this value is constant for all same size
NOS-loaded liposomes (Figure 4.11).
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As explained in Chapter 3, Section 3.3 a set of control experiments were carried
out to confirm that the current response is due to NO released from NOS-loaded
liposomes. When the enzyme is inhibited by adding L-NAME, no current response was
observed upon the addition of NADPH, as shown in Figure 4.12. the addition of NADPH
to the bulk solution does not give any significant signal indicating that the sensor
response is due to NO released from NOS encapsulated in liposomes.

200pA

Current/pA

300s

Buffer
45 nmol
NADPH

Time/s

Figure 4.10. Amperometric response of our NO sensor after addition of
NADPH and PBS buffer solution to the NOS-encapsulated liposome.
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Figure. 4.11. Amperometric response of our NO sensor for the addition of
NADPH close to the NOS-encapsulated liposomes and in bulk solution.
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200pA
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Figure 4.12. Amperometric response of the modified electrode for the addition
of NADPH to the NOS-encapsulated liposome after the L-NAME treatment.
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4.4 Summary of Chapter IV

The NOS-loaded liposomes were obtained by the thin film hydration method. We
were able to prepare stable liposomes loaded with NOS enzyme with an encapsulation
efficiency of 40 ± 25%. Size monitoring with DLS demonstrate the excellent stability of
NOS-loaded liposome for around 15 days upon storage and NOS-enzyme activity also
retained. The Griess assay results revealed that each batch of NOS-loaded liposomes can
produce 3.5 µM of NO. Dynamic electrochemical measurement of NO indicates that 19.8
nM of NO are released from an isolated single liposome. These positive results confirmed
that the enzyme activity is retained inside the liposome, and it can release NO upon
stimulation.
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CHAPTER V

FUTURE DIRECTIONS - THE INVESTIGATION OF CELLULAR UPTAKE OF
NOS ENZYME FROM NOS-LOAD LIPOSOMES

5.1. Introduction

As discussed in previous chapters, a change in physiological concentration of NO
causes severe problems in biological systems. The logical therapy for NO deficient
conditions such as, hypertension [1, 2], impotence [3, 4], hyperglycaemia, arteriosclerosis
[5, 6], is the supply of NO or NOS to targets. In Chapter IV, we described the
development of an effective method to entrap NOS enzymes in liposomes as a
prospective vehicle for onsite NO delivery. Liposomes have emerged as efficient and
versatile carrier system due to their capability to entrap a verity of substances, such as
drugs, proteins, antibodies, etc. By virtue of their biocompatible lipid exterior, liposomes
are considered as a powerful tools for delivery as they can introduce various biologically
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active materials into cells both in vivo and in vitro. Initial studies of vesicle-cell
interactions demonstrated that the compounds in the vesicles can be released to cells, and
hence affect cell functions. Although several studies have investigated the cellular
interactions with liposomes, less attention has been given to the mechanism of liposomes’
incorporation into cells [7-9].

There are several ways of interaction of liposomes and cells for delivering
liposomal content inside cells. Without interruption of liposomes integrity phospholipid
bilayers can approach close to cell membrane and foster intermembrane transfer. Four
mechanisms have been proposed that can explain the liposome-cell interactions by which
liposomes can deliver their content to cells (Figure 5.1). Liposomes can adsorb onto the
cell membrane and then promote the extracellular release of the liposomal content, which
can transfer into the cells by active or passive transport (path 1 in Figure 5.1) [11].
Secondly, adsorbed liposome can selectively transfer lipophilic compounds from the
liposomal bilayer to the cell interior as shown in Figure 5.1, path 2 [12]. The most
common mechanism is the endocytosis (Figure 5.1, path 3), where the endocytotic
internalization of the liposome occurs, followed by the intracellular degradation and
subsequent intracellular delivery of substances [9, 13, 14]. Fusion is the fourth method
and consist of direct and simple delivery mechanism (Figure 5.1, path 4). In fusion, the
plasma membrane and the vesicle membrane fuse and incorporate together, which results
in the release of the content into the cytoplasm [15].
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Figure 5.1. Schematic representation of the possible mechanism by which the
liposomes can interact with cells in vitro and deliver their content (Adapted from [10])
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The aim of this chapter is the investigation of the effectiveness of NOS loaded liposome
for intracellular delivery. The goal is to deliver liposome-entrapped NOS inside the cells while
retaining enzyme activity. The NOS-loaded liposomes prepared as pointed out in Chapter IV will
be used for the intracellular NOS delivery into cultured human embroyonic kidney cells

(HEK 293). The procedure and the preliminary results are discussed.

5.2 Experimental Section

5.2.1 Materials and Apparatus

All the materials for electrochemistry are used as indicated in Section 2.2.1 and
similar experimental set-up and instrumentation is used as outlined in Section 2.2.2. Cell
experiments were carried out on the stage of an Olympus IX 71 inverted microscope,
Center Valley, PA.

5.2.2 Liposome Preparation

Liposomes were prepared by thin-film hydration method as described in Chapter
IV, Section, 4.2.3. All experiments were done in sterilized conditions. Liposome
preparation was also carried out under aseptic conditions. After the liposome extrution
the suspension was sterile-filtered through 0.2 µm membranes (Millipore, Jaffrey, NH).
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5.2.3

Cell Culture Preparation

Human embryonic kidney cell cultures (HEK-293) were grown in Eagle's
Minimum Essential Medium (MEM) with 4 mM L-glutamine, 4.5 g/L glucose, 10% fetal
bovine serum and adjusted to contain 1.5 g/L sodium bicarbonate. The cells were grown
and sub-cultured as described in the Section, 3.2.3.

5.2.4.

In vitro liposome-cell interaction

HEK cells were grown in petri dishes (3.0 cm diameter) in the MEM medium and
at the confluence (4.2 x 105 cells/ml), the media was removed and replaced with MEM
containing 1% Insulin-transfering-sodium selenite (MEM + ITS) [16]. The sterilized
NOS- loaded liposomes at the concentration of 0.5 µmol lipids/ml were incubated with
HEK cells. After 2 days of incubation at 37 oC, the media was removed and the cells
were washed three times with a PBS buffer. As controls, HEK cells were grown with the
addition of empty liposomes (without NOS) and without the addition of any liposomes.
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5.2.5. Electrochemical Experiments

Electrochemical experiments of NOS-loaded liposomes were carried out as
described previously (Section 4.2.2) for HEK cells incubated with liposomes and for
controls. NO synthesis was triggered by adding the NOS substrate L-Arginine (1.5 mM)
[17].

5.3. Preliminary Results and Discussion

After injecting 1.5mM of L-arginine close to the collection of HEK cells, the
changes in the current signal were monitored as described in Section 3.3.1. The typical
current-time plot obtained for HEK cells without NOS-loaded liposomes is shown in
Figure 5.2. We observed a change in current immediately after the addition of Larginine. The HEK cells incubated with empty liposomes (without NOS) also gave the
similar current response as Figure 5.2. This indicates that there is no effect from the
liposomes for the functions of HEK cells.

To make sure that the NO released comes from stimulated HEK cells, a set of
control experiments were carried out as explained before. First, the cells were treated
with the nitric oxide synthase (NOS) inhibitor, L-NAME, prior to the experiment. As
shown in Figure 5.3, no significant change in current response is observed for the
addition of L-arginine to the L-NAME treated HEK cells. To ensure that the injection
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process did not cause the current change, an equivalent volume (50 µl) of phosphate
buffer (PBS) was injected into the solution close to the cells in lieu of L-arginine and no
significant change in the background current was observed. Also as shown in Figure 5.4,
when L-arginine was injected to buffer solution without cells, there was no current
change. These results indicate that the current response obtained in Figure 5.3 was totally
due to the NO produced from HEK cells.

10pA

Current/pA

200s

1.5 mM L-Arg

1.5 mM L-Arg

Time/s
Figure 5.2. Amperometric response of NO sensor after addition of LArginine to the HEK cell culture.
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Figure 5.3. Amperometric response of our NO sensor after addition of LArginine to the cell culture treated with the NOS inhibitor L-NAME
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Figure 5.4 Amperometric response of our NO sensor after addition of LArginine to the PBS solution.
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The same electrochemical experiments were carried out for the HEK cells that
were incubated with 0.5 µmol lipids/ml NOS-loaded liposomes. When L-arginine was
injected near to the cell surface, a current response greater than cells not subjected to
liposome treatment was observed (Figure 5.5). According to the calibration plot obtained
in the same experimental conditions (Chapter III, Figure 3.10), the NO generated from
HEK cells incubated with NOS-loaded liposomes is about 10 nM. Compared to the
normal production of NO by HEK cells (1 nM), this value is about 10 times higher,
supporting the idea that NOS enzyme from liposomes were delivered inside HEK cells
from the NOS-loaded liposomes.

The amount of NO produced by transferring the NOS enzyme from liposomes to
cells is much lower compared to the total amount of NO production by NOS-loaded
liposomes themselves. Our results show that only about 10 % of active enzymes are
delivered from NOS-loaded liposomes to cell interior. This can be explained by
analyzing the NO production from the medium and the washings that removed from HEK
cells after incubation with NOS-loaded liposomes. Griess assay analysis results shows
that about 0.56 µM of NO produced from the washings. This indicates a potential leakage
of NOS enzymes from the liposomes in the experimental conditions described above.
Some of the possible modifications and conditions for optimized enzyme delivery are
discussed bellow. Although the values are in the low end of internalization of NOS, our
method provide novel platform for targeted NOS delivery.
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Figure 5.5. Amperometric response of our NO sensor after addition of
L-Arginine to the HEK cell culture that incubated with NOS-loaded liposome.
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As an effective drug delivery system, liposomes must reach the target site after
passing through the blood flow and release their content to the target site. Then the target
tissues /cells should uptake the liposomal content to cure the disease or change the
functions. As explained in the introduction, fusion, adsorption and the endocytosis occur
when delivering liposomal content into cells. It has been found that the optimum
condition of intracellular delivery of liposomal content to cells is similar in vivo and in
vitro [13]. Therefore, the study of cellular uptake of liposomes in vitro condition is vital.
Liposomes bearing a negative charge (such as liposomes formed with phosphatidylserine
(PS), phosphatidylglycerol (PG), or phosphatidic acid (PA) lipids) were observed to be
endocytosed in macrophages to a greater extent than neutral liposomes [9, 13, 14]. Some
cell types, including macrophages, can recognize negatively charged liposomes more
successfully [7, 13, 14, 18]. The Hela cells have been found to uptake positively charged
liposomes more preferentially and this interaction is reliable with nonspecific binding
rather than involving a specific receptor [19]. However, the factors that affect the binding
of liposome into cells have not yet been clearly deliniated. Therefore, using a similar
approach, we will develop NOS-loaded liposomes by varying the charge, the composition
of lipids, to maximize uptake of liposomal content.

The biocompatible polymer, poly (ethylene glycol) (PEG) is a good candidate for
preparation of satirically stabilized liposomes. PEG modified membrane can prevent the
clearance of liposomes in the blood stream [19]. Immobilizing liposomes onto
biodegradable solid materials, can result in effective delivery to targets, with low dosage,
minimal side effects, and long term circulation. As an approach of the clinical
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applications, PEG-Biotin-tag NOS-loaded liposomes will be prepared as shown in Figure
5.6. The solution phase AFM characterization of such a Biotin-tag NOS-loaded
liposomes on streptavidine modified mica surface shown in Figure 5.7. Further studies
are in process to optimize the stability and delivery to achieve more stable vesicles for
on-site NO delivery.

Figure 5.6. Schematic representation of immobilized Biotin-tag NOS-loaded liposome
on solid carrier. (Reprinted from [20])
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Figure 5.7. Solution phase AFM image of biotin-tag NOS-loaded liposome
on mica surface
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